%% This BibTeX bibliography file was created using BibDesk.
%% http://bibdesk.sourceforge.net/

%% Created for Jake Gockley at 2016-09-01 13:31:20 -0400 


%% Saved with string encoding Unicode (UTF-8) 



@article{OBrien:2004aa,
	Abstract = {In this article a short overview is given of the relationship between autism and learning disability. Autism exists with any level of intelligence, but many individuals with autism suffer also from learning disability. Although both disorders show overlap in some behaviours they are different in many aspects. Are they distinct syndromes which influence each other, or do they belong to a broad spectrum of a condition?},
	Author = {O'Brien, Gregory and Pearson, Joanne},
	Date-Added = {2016-09-01 17:30:52 +0000},
	Date-Modified = {2016-09-01 17:30:52 +0000},
	Doi = {10.1177/1362361304042718},
	Journal = {Autism},
	Journal-Full = {Autism : the international journal of research and practice},
	Mesh = {Adaptation, Psychological; Autistic Disorder; Child; Communication; Comorbidity; Humans; Intelligence; Learning Disorders; Social Behavior},
	Month = {Jun},
	Number = {2},
	Pages = {125-40},
	Pmid = {15165430},
	Pst = {ppublish},
	Title = {Autism and learning disability},
	Volume = {8},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1177/1362361304042718}}

@article{Constantino:2005aa,
	Abstract = {BACKGROUND: Autistic disorder (AD) is a disabling oligogenic condition characterized by severe social impairment. Subthreshold autistic social impairments are known to aggregate in the family members of autistic probands; therefore, we conducted this study to examine the intergenerational transmission of such traits in the general population.
METHODS: The Social Responsiveness Scale (SRS), a quantitative measure of autistic traits, was completed on 285 pairs of twins (by maternal report) and on their parents (by spouse report).
RESULTS: Correlation for social impairment or competence between parents and their children and between spouses was on the order of .4. In families in which both parents scored in the upper quartile for social impairment on the SRS, mean SRS score of offspring was significantly elevated (effect size 1.5). Estimated assortative mating explained approximately 30% of the variation in parent SRS scores.
CONCLUSIONS: Children from families in which both parents manifest subthreshold autistic traits exhibit a substantial shift in the distribution of their scores for impairment in reciprocal social behavior, toward the pathological end. As has been previously demonstrated in children, heritable subthreshold autistic impairments are measurable in adults and appear continuously distributed in the general population.},
	Author = {Constantino, John N and Todd, Richard D},
	Date-Added = {2016-07-28 19:07:00 +0000},
	Date-Modified = {2016-07-28 19:07:00 +0000},
	Doi = {10.1016/j.biopsych.2004.12.014},
	Journal = {Biol Psychiatry},
	Journal-Full = {Biological psychiatry},
	Mesh = {Adolescent; Adult; Autistic Disorder; Child; Child Development Disorders, Pervasive; Diagnostic and Statistical Manual of Mental Disorders; Diseases in Twins; Family Health; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Intergenerational Relations; Interview, Psychological; Male; Mental Competency; Middle Aged; Parent-Child Relations; Psychometrics; Severity of Illness Index; Social Behavior; Twin Studies as Topic},
	Month = {Mar},
	Number = {6},
	Pages = {655-60},
	Pmid = {15780853},
	Pst = {ppublish},
	Title = {Intergenerational transmission of subthreshold autistic traits in the general population},
	Volume = {57},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.biopsych.2004.12.014}}

@article{Price:2006aa,
	Abstract = {Population stratification--allele frequency differences between cases and controls due to systematic ancestry differences-can cause spurious associations in disease studies. We describe a method that enables explicit detection and correction of population stratification on a genome-wide scale. Our method uses principal components analysis to explicitly model ancestry differences between cases and controls. The resulting correction is specific to a candidate marker's variation in frequency across ancestral populations, minimizing spurious associations while maximizing power to detect true associations. Our simple, efficient approach can easily be applied to disease studies with hundreds of thousands of markers.},
	Author = {Price, Alkes L and Patterson, Nick J and Plenge, Robert M and Weinblatt, Michael E and Shadick, Nancy A and Reich, David},
	Date-Added = {2016-07-13 20:20:35 +0000},
	Date-Modified = {2016-07-13 20:20:35 +0000},
	Doi = {10.1038/ng1847},
	Journal = {Nat Genet},
	Journal-Full = {Nature genetics},
	Mesh = {Algorithms; Alleles; Case-Control Studies; Databases, Nucleic Acid; Genetic Markers; Genome, Human; Genomics; Genotype; Humans; Phenotype; Polymorphism, Single Nucleotide; Principal Component Analysis},
	Month = {Aug},
	Number = {8},
	Pages = {904-9},
	Pmid = {16862161},
	Pst = {ppublish},
	Title = {Principal components analysis corrects for stratification in genome-wide association studies},
	Volume = {38},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/ng1847}}

@article{Faul:2007aa,
	Abstract = {G*Power (Erdfelder, Faul, & Buchner, 1996) was designed as a general stand-alone power analysis program for statistical tests commonly used in social and behavioral research. G*Power 3 is a major extension of, and improvement over, the previous versions. It runs on widely used computer platforms (i.e., Windows XP, Windows Vista, and Mac OS X 10.4) and covers many different statistical tests of the t, F, and chi2 test families. In addition, it includes power analyses for z tests and some exact tests. G*Power 3 provides improved effect size calculators and graphic options, supports both distribution-based and design-based input modes, and offers all types of power analyses in which users might be interested. Like its predecessors, G*Power 3 is free.},
	Author = {Faul, Franz and Erdfelder, Edgar and Lang, Albert-Georg and Buchner, Axel},
	Date-Added = {2016-07-13 20:20:12 +0000},
	Date-Modified = {2016-07-13 20:20:12 +0000},
	Journal = {Behav Res Methods},
	Journal-Full = {Behavior research methods},
	Mesh = {Algorithms; Behavioral Sciences; Biomedical Research; Data Interpretation, Statistical; Mathematical Computing; Microcomputers; Sensitivity and Specificity; Social Sciences; Software; Statistics, Nonparametric},
	Month = {May},
	Number = {2},
	Pages = {175-91},
	Pmid = {17695343},
	Pst = {ppublish},
	Title = {G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences},
	Volume = {39},
	Year = {2007}}

@article{Duan:2008aa,
	Abstract = {UNLABELLED: The International HapMap Project has recently made available genotypes and frequency data for phase 3 (NCBI build 36, dbSNPb129) of the HapMap providing an enriched genotype dataset for approximately 1.6 million single nucleotide polymorphisms (SNPs) from 1,115 individuals with ancestry from parts of Africa, Asia, Europe, North America and Mexico. In the present study, we aim to facilitate pharmacogenetics studies by providing a database of SNPs with high population differentiation through a genomewide test on allele frequency variation among 11 HapMap3 samples. Common SNPs with minor allele frequency greater than 5 cent from each of 11 HapMap3 samples were included in the present analysis. The population differentiation is measured in terms of fixation index (Fst), and the SNPs with Fst values over 0.5 were defined as highly differentiated SNPs. Our tests were carried out between all pairs of the 11 HapMap3 samples or among subgroups with the same continental ancestries. Altogether we carried out 64 genomewide Fst tests and identified 28,215 highly differentiated SNPs for 49 different combinations of HapMap3 samples in the current database.
AVAILABILITY: http://FstSNP-hapmap3.googlecode.com/},
	Author = {Duan, Shiwei and Zhang, Wei and Cox, Nancy Jean and Dolan, Mary Eileen},
	Date-Added = {2016-07-13 20:19:50 +0000},
	Date-Modified = {2016-07-13 20:19:50 +0000},
	Journal = {Bioinformation},
	Journal-Full = {Bioinformation},
	Keywords = {Fst; HapMap3; SNP; database; human genome; population differentiation},
	Number = {3},
	Pages = {139-41},
	Pmc = {PMC2639690},
	Pmid = {19238253},
	Pst = {ppublish},
	Title = {FstSNP-HapMap3: a database of SNPs with high population differentiation for HapMap3},
	Volume = {3},
	Year = {2008}}

@article{Anderson:2010aa,
	Abstract = {This protocol details the steps for data quality assessment and control that are typically carried out during case-control association studies. The steps described involve the identification and removal of DNA samples and markers that introduce bias. These critical steps are paramount to the success of a case-control study and are necessary before statistically testing for association. We describe how to use PLINK, a tool for handling SNP data, to perform assessments of failure rate per individual and per SNP and to assess the degree of relatedness between individuals. We also detail other quality-control procedures, including the use of SMARTPCA software for the identification of ancestral outliers. These platforms were selected because they are user-friendly, widely used and computationally efficient. Steps needed to detect and establish a disease association using case-control data are not discussed here. Issues concerning study design and marker selection in case-control studies have been discussed in our earlier protocols. This protocol, which is routinely used in our labs, should take approximately 8 h to complete.},
	Author = {Anderson, Carl A and Pettersson, Fredrik H and Clarke, Geraldine M and Cardon, Lon R and Morris, Andrew P and Zondervan, Krina T},
	Date-Added = {2016-07-13 20:19:20 +0000},
	Date-Modified = {2016-07-13 20:19:20 +0000},
	Doi = {10.1038/nprot.2010.116},
	Journal = {Nat Protoc},
	Journal-Full = {Nature protocols},
	Mesh = {Animals; Case-Control Studies; Computational Biology; Female; Genetic Techniques; Genome-Wide Association Study; Humans; Male; Quality Control},
	Month = {Sep},
	Number = {9},
	Pages = {1564-73},
	Pmc = {PMC3025522},
	Pmid = {21085122},
	Pst = {ppublish},
	Title = {Data quality control in genetic case-control association studies},
	Volume = {5},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nprot.2010.116}}

@article{Emera:2016aa,
	Abstract = {Morphological innovations such as the mammalian neocortex may involve the evolution of novel regulatory sequences. However, de novo birth of regulatory elements active during morphogenesis has not been extensively studied in mammals. Here, we use H3K27ac-defined regulatory elements active during human and mouse corticogenesis to identify enhancers that were likely active in the ancient mammalian forebrain. We infer the phylogenetic origins of these enhancers and find that âˆ¼20% arose in the mammalian stem lineage, coincident with the emergence of the neocortex. Implementing a permutation strategy that controls for the nonrandom variation in the ages of background genomic sequences, we find that mammal-specific enhancers are overrepresented near genes involved in cell migration, cell signaling, and axon guidance. Mammal-specific enhancers are also overrepresented in modules of coexpressed genes in the cortex that are associated with these pathways, notably ephrin and semaphorin signaling. Our results also provide insight into the mechanisms of regulatory innovation in mammals. We find that most neocortical enhancers did not originate by en bloc exaptation of transposons. Young neocortical enhancers exhibit smaller H3K27ac footprints and weaker evolutionary constraint in eutherian mammals than older neocortical enhancers. Based on these observations, we present a model of the enhancer life cycle in which neocortical enhancers initially emerge from genomic background as short, weakly constrained "proto-enhancers." Many proto-enhancers are likely lost, but some may serve as nucleation points for complex enhancers to evolve.},
	Author = {Emera, Deena and Yin, Jun and Reilly, Steven K and Gockley, Jake and Noonan, James P},
	Date-Added = {2016-07-09 22:01:12 +0000},
	Date-Modified = {2016-07-09 22:01:12 +0000},
	Doi = {10.1073/pnas.1603718113},
	Journal = {Proc Natl Acad Sci U S A},
	Journal-Full = {Proceedings of the National Academy of Sciences of the United States of America},
	Keywords = {brain evolution; epigenetics; neocortical development; regulatory innovation},
	Month = {May},
	Number = {19},
	Pages = {E2617-26},
	Pmc = {PMC4868431},
	Pmid = {27114548},
	Pst = {ppublish},
	Title = {Origin and evolution of developmental enhancers in the mammalian neocortex},
	Volume = {113},
	Year = {2016},
	Bdsk-Url-1 = {http://dx.doi.org/10.1073/pnas.1603718113}}

@article{Gockley:2015aa,
	Abstract = {BACKGROUND: A 4:1 male to female sex bias has consistently been observed in autism spectrum disorder (ASD). Epidemiological and genetic studies suggest a female protective effect (FPE) may account for part of this bias; however, the mechanism of such protection is unknown. Quantitative assessment of ASD symptoms using the Social Responsiveness Scale (SRS) shows a bimodal distribution unique to females in multiplex families. This leads to the hypothesis that a single, common genetic locus on chromosome X might mediate the FPE and produce the ASD sex bias. Such a locus would represent a major therapeutic target and is likely to have been missed by conventional genome-wide association study (GWAS) analysis.
METHODS: To explore this possibility, we performed an association study in affected versus unaffected females, considering three tiers of single nucleotide polymorphisms (SNPs) as follows: 1) regions of chromosome X that escape X-inactivation, 2) all of chromosome X, and 3) genome-wide.
RESULTS: No evidence of a SNP meeting the criteria for a single FPE locus was observed, despite the analysis being well powered to detect this effect.
CONCLUSIONS: The results do not support the hypothesis that the FPE is mediated by a single genetic locus; however, this does not exclude the possibility of multiple genetic loci playing a role in the FPE.},
	Author = {Gockley, Jake and Willsey, A Jeremy and Dong, Shan and Dougherty, Joseph D and Constantino, John N and Sanders, Stephan J},
	Date-Added = {2016-07-09 22:01:05 +0000},
	Date-Modified = {2016-07-09 22:01:05 +0000},
	Doi = {10.1186/s13229-015-0014-3},
	Journal = {Mol Autism},
	Journal-Full = {Molecular autism},
	Keywords = {Autism spectrum disorder; Female protective effect; GWAS; Sex bias},
	Pages = {25},
	Pmc = {PMC4429476},
	Pmid = {25973162},
	Pst = {epublish},
	Title = {The female protective effect in autism spectrum disorder is not mediated by a single genetic locus},
	Volume = {6},
	Year = {2015},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/s13229-015-0014-3}}

@article{Anney:2012aa,
	Abstract = {While it is apparent that rare variation can play an important role in the genetic architecture of autism spectrum disorders (ASDs), the contribution of common variation to the risk of developing ASD is less clear. To produce a more comprehensive picture, we report Stage 2 of the Autism Genome Project genome-wide association study, adding 1301 ASD families and bringing the total to 2705 families analysed (Stages 1 and 2). In addition to evaluating the association of individual single nucleotide polymorphisms (SNPs), we also sought evidence that common variants, en masse, might affect the risk. Despite genotyping over a million SNPs covering the genome, no single SNP shows significant association with ASD or selected phenotypes at a genome-wide level. The SNP that achieves the smallest P-value from secondary analyses is rs1718101. It falls in CNTNAP2, a gene previously implicated in susceptibility for ASD. This SNP also shows modest association with age of word/phrase acquisition in ASD subjects, of interest because features of language development are also associated with other variation in CNTNAP2. In contrast, allele scores derived from the transmission of common alleles to Stage 1 cases significantly predict case status in the independent Stage 2 sample. Despite being significant, the variance explained by these allele scores was small (Vm< 1%). Based on results from individual SNPs and their en masse effect on risk, as inferred from the allele score results, it is reasonable to conclude that common variants affect the risk for ASD but their individual effects are modest.},
	Author = {Anney, Richard and Klei, Lambertus and Pinto, Dalila and Almeida, Joana and Bacchelli, Elena and Baird, Gillian and Bolshakova, Nadia and B{\"o}lte, Sven and Bolton, Patrick F and Bourgeron, Thomas and Brennan, Sean and Brian, Jessica and Casey, Jillian and Conroy, Judith and Correia, Catarina and Corsello, Christina and Crawford, Emily L and de Jonge, Maretha and Delorme, Richard and Duketis, Eftichia and Duque, Frederico and Estes, Annette and Farrar, Penny and Fernandez, Bridget A and Folstein, Susan E and Fombonne, Eric and Gilbert, John and Gillberg, Christopher and Glessner, Joseph T and Green, Andrew and Green, Jonathan and Guter, Stephen J and Heron, Elizabeth A and Holt, Richard and Howe, Jennifer L and Hughes, Gillian and Hus, Vanessa and Igliozzi, Roberta and Jacob, Suma and Kenny, Graham P and Kim, Cecilia and Kolevzon, Alexander and Kustanovich, Vlad and Lajonchere, Clara M and Lamb, Janine A and Law-Smith, Miriam and Leboyer, Marion and Le Couteur, Ann and Leventhal, Bennett L and Liu, Xiao-Qing and Lombard, Frances and Lord, Catherine and Lotspeich, Linda and Lund, Sabata C and Magalhaes, Tiago R and Mantoulan, Carine and McDougle, Christopher J and Melhem, Nadine M and Merikangas, Alison and Minshew, Nancy J and Mirza, Ghazala K and Munson, Jeff and Noakes, Carolyn and Nygren, Gudrun and Papanikolaou, Katerina and Pagnamenta, Alistair T and Parrini, Barbara and Paton, Tara and Pickles, Andrew and Posey, David J and Poustka, Fritz and Ragoussis, Jiannis and Regan, Regina and Roberts, Wendy and Roeder, Kathryn and Roge, Bernadette and Rutter, Michael L and Schlitt, Sabine and Shah, Naisha and Sheffield, Val C and Soorya, Latha and Sousa, In{\^e}s and Stoppioni, Vera and Sykes, Nuala and Tancredi, Raffaella and Thompson, Ann P and Thomson, Susanne and Tryfon, Ana and Tsiantis, John and Van Engeland, Herman and Vincent, John B and Volkmar, Fred and Vorstman, J A S and Wallace, Simon and Wing, Kirsty and Wittemeyer, Kerstin and Wood, Shawn and Zurawiecki, Danielle and Zwaigenbaum, Lonnie and Bailey, Anthony J and Battaglia, Agatino and Cantor, Rita M and Coon, Hilary and Cuccaro, Michael L and Dawson, Geraldine and Ennis, Sean and Freitag, Christine M and Geschwind, Daniel H and Haines, Jonathan L and Klauck, Sabine M and McMahon, William M and Maestrini, Elena and Miller, Judith and Monaco, Anthony P and Nelson, Stanley F and Nurnberger, Jr, John I and Oliveira, Guiomar and Parr, Jeremy R and Pericak-Vance, Margaret A and Piven, Joseph and Schellenberg, Gerard D and Scherer, Stephen W and Vicente, Astrid M and Wassink, Thomas H and Wijsman, Ellen M and Betancur, Catalina and Buxbaum, Joseph D and Cook, Edwin H and Gallagher, Louise and Gill, Michael and Hallmayer, Joachim and Paterson, Andrew D and Sutcliffe, James S and Szatmari, Peter and Vieland, Veronica J and Hakonarson, Hakon and Devlin, Bernie},
	Date-Added = {2016-07-09 21:39:44 +0000},
	Date-Modified = {2016-07-09 21:39:44 +0000},
	Doi = {10.1093/hmg/dds301},
	Journal = {Hum Mol Genet},
	Journal-Full = {Human molecular genetics},
	Mesh = {Alleles; Child; Child Development Disorders, Pervasive; Female; Gene Frequency; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Language Development; Male; Membrane Proteins; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Risk Factors},
	Month = {Nov},
	Number = {21},
	Pages = {4781-92},
	Pmc = {PMC3471395},
	Pmid = {22843504},
	Pst = {ppublish},
	Title = {Individual common variants exert weak effects on the risk for autism spectrum disorderspi},
	Volume = {21},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/hmg/dds301}}

@article{Constantino:2003aa,
	Abstract = {BACKGROUND: Recent research has indicated that autism is not a discrete disorder and that family members of autistic probands have an increased likelihood of exhibiting autistic symptoms with a wide range of severity, often below the threshold for a diagnosis of an autism spectrum disorder.
OBJECTIVE: To examine the distribution and genetic structure of autistic traits in the general population using a newly established quantitative measure of autistic traits, the Social Responsiveness Scale (formerly known as the Social Reciprocity Scale).
METHODS: The sample consisted of 788 pairs of twins aged 7 to 15 years, randomly selected from the pool of participants in a large epidemiologic study (the Missouri Twin Study). One parent of each pair of twins completed the Social Responsiveness Scale on each child. The data were subjected to structural equation modeling.
RESULTS: Autistic traits as measured by the Social Responsiveness Scale were continuously distributed and moderately to highly heritable. Levels of severity of autistic traits at or above the previously published mean for patients with pervasive developmental disorder not otherwise specified were found in 1.4% of boys and 0.3% of girls. Structural equation modeling revealed no evidence for the existence of sex-specific genetic influences, and suggested specific mechanisms by which females may be relatively protected from vulnerability to autistic traits.
CONCLUSIONS: These data indicate that the social deficits characteristic of autism spectrum disorders are common. Given the continuous distribution of these traits, it may be arbitrary where cutoffs are made between research designations of being "affected" vs "unaffected" with a pervasive developmental disorder. The genes influencing autistic traits appear to be the same for boys and girls. Lower prevalence (and severity) of autistic traits in girls may be the result of increased sensitivity to early environmental influences that operate to promote social competency.},
	Author = {Constantino, John N and Todd, Richard D},
	Date-Added = {2016-07-09 21:37:24 +0000},
	Date-Modified = {2016-07-09 21:37:24 +0000},
	Doi = {10.1001/archpsyc.60.5.524},
	Journal = {Arch Gen Psychiatry},
	Journal-Full = {Archives of general psychiatry},
	Mesh = {Adolescent; Autistic Disorder; Child; Child Development Disorders, Pervasive; Diseases in Twins; Family; Female; Genetic Predisposition to Disease; Humans; Male; Missouri; Sampling Studies; Severity of Illness Index; Sex Factors; Social Responsibility},
	Month = {May},
	Number = {5},
	Pages = {524-30},
	Pmid = {12742874},
	Pst = {ppublish},
	Title = {Autistic traits in the general population: a twin study},
	Volume = {60},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1001/archpsyc.60.5.524}}

@article{Kamio:2013aa,
	Abstract = {Individuals of normal intelligence with autism spectrum disorders (ASD) tend to be diagnosed with ASD late in childhood or sometimes in adulthood, despite a persistent symptomatology. When such patients visit psychiatric clinics for co-occurring psychiatric symptoms, the diagnostic procedure can be challenging due to a lack of accurate developmental information and a mixed clinical presentation. The same is true for those with subthreshold autistic symptoms. Although individuals with subthreshold ASD also have social adjustment difficulties of a similar degree to those with ASD, the relative clinical significance of this population is unclear. Here, data from a large national population sample of schoolchildren were examined to determine the psychiatric needs of children with threshold and subthreshold autistic symptoms. First, autistic symptoms or traits assessed by the Social Responsiveness Scale (SRS), a quantitative behavioral measure, showed a continuous distribution in the general child population (n = 22,529), indicating no evidence of a natural gap that could differentiate children diagnosed with ASD from subthreshold or unaffected children. Second, data from 25,075 children demonstrated that having threshold autistic symptoms predicted a high psychiatric risk, as indicated by higher scores on the Strengths and Difficulties Questionnaire (SDQ; odds ratio [OR] 200.52, 95% confidence interval [CI]: 152.12-264.33), and that having subthreshold autistic symptoms indicated the same (OR 12.78, 95% CI: 11.52-14.18). Having threshold autistic symptoms predicted emotional problems (OR 20.19, 95% CI: 17.00-24.00), as did having subthreshold autistic symptoms (OR 5.90, 95% CI: 5.29-6.58). Third, among 2,250 children at a high psychiatric risk, most had threshold or subthreshold autistic symptoms (21 and 44%, respectively). These findings have important implications for the comprehensive psychiatric and developmental evaluation and treatment of this patient population, whose diagnosis and treatment are often delayed, and a further in-depth study is warranted.},
	Author = {Kamio, Yoko and Moriwaki, Aiko and Takei, Reiko and Inada, Naoko and Inokuchi, Eiko and Takahashi, Hidetoshi and Nakahachi, Takayuki},
	Date-Added = {2016-07-09 21:36:36 +0000},
	Date-Modified = {2016-07-09 21:36:36 +0000},
	Journal = {Seishin Shinkeigaku Zasshi},
	Journal-Full = {Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica},
	Mesh = {Adult; Age Distribution; Child; Child Development Disorders, Pervasive; Humans; Incidence; Japan; Risk; Social Behavior},
	Number = {6},
	Pages = {601-6},
	Pmid = {23944117},
	Pst = {ppublish},
	Title = {[Psychiatric issues of children and adults with autism spectrum disorders who remain undiagnosed]},
	Volume = {115},
	Year = {2013}}

@article{He:2013aa,
	Abstract = {De novo mutations affect risk for many diseases and disorders, especially those with early-onset. An example is autism spectrum disorders (ASD). Four recent whole-exome sequencing (WES) studies of ASD families revealed a handful of novel risk genes, based on independent de novo loss-of-function (LoF) mutations falling in the same gene, and found that de novo LoF mutations occurred at a twofold higher rate than expected by chance. However successful these studies were, they used only a small fraction of the data, excluding other types of de novo mutations and inherited rare variants. Moreover, such analyses cannot readily incorporate data from case-control studies. An important research challenge in gene discovery, therefore, is to develop statistical methods that accommodate a broader class of rare variation. We develop methods that can incorporate WES data regarding de novo mutations, inherited variants present, and variants identified within cases and controls. TADA, for Transmission And De novo Association, integrates these data by a gene-based likelihood model involving parameters for allele frequencies and gene-specific penetrances. Inference is based on a Hierarchical Bayes strategy that borrows information across all genes to infer parameters that would be difficult to estimate for individual genes. In addition to theoretical development we validated TADA using realistic simulations mimicking rare, large-effect mutations affecting risk for ASD and show it has dramatically better power than other common methods of analysis. Thus TADA's integration of various kinds of WES data can be a highly effective means of identifying novel risk genes. Indeed, application of TADA to WES data from subjects with ASD and their families, as well as from a study of ASD subjects and controls, revealed several novel and promising ASD candidate genes with strong statistical support.},
	Author = {He, Xin and Sanders, Stephan J and Liu, Li and De Rubeis, Silvia and Lim, Elaine T and Sutcliffe, James S and Schellenberg, Gerard D and Gibbs, Richard A and Daly, Mark J and Buxbaum, Joseph D and State, Matthew W and Devlin, Bernie and Roeder, Kathryn},
	Date-Added = {2016-07-09 21:28:41 +0000},
	Date-Modified = {2016-07-09 21:28:41 +0000},
	Doi = {10.1371/journal.pgen.1003671},
	Journal = {PLoS Genet},
	Journal-Full = {PLoS genetics},
	Mesh = {Bayes Theorem; Case-Control Studies; Child Development Disorders, Pervasive; Exome; Genetic Predisposition to Disease; Genetic Variation; Humans; Likelihood Functions; Models, Theoretical; Mutation; Risk Factors; Sequence Analysis, DNA},
	Number = {8},
	Pages = {e1003671},
	Pmc = {PMC3744441},
	Pmid = {23966865},
	Pst = {ppublish},
	Title = {Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes},
	Volume = {9},
	Year = {2013},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pgen.1003671}}

@article{Goin-Kochel:2007aa,
	Abstract = {Both the broad and narrow phenotypes of autism have been consistently observed in family members of affected individuals. Additionally, autism spectrum disorders (ASDs) present four times more often in males than in females, for reasons that are currently unknown. In this study, we examined whether there were differences in familial loading of ASD among families of male versus female probands. Analyses were conducted with existing data from two distinct samples. The first sample contained 417 individuals with autism and Asperger's disorder and included information on the ASD diagnoses of their first- and second-degree relatives. The second sample consisted of 405 sibships participating in the Autism Genetic Resource Exchange, of which one or more siblings had an ASD diagnosis. Results from both samples did not suggest significant differences in the prevalence of ASD among relatives of affected males versus females.},
	Author = {Goin-Kochel, Robin P and Abbacchi, Anna and Constantino, John N and {Autism Genetic Resource Exchange Consortium}},
	Date-Added = {2016-07-09 21:00:14 +0000},
	Date-Modified = {2016-07-09 21:00:14 +0000},
	Doi = {10.1177/1362361307076857},
	Journal = {Autism},
	Journal-Full = {Autism : the international journal of research and practice},
	Mesh = {Adult; Asperger Syndrome; Autistic Disorder; Child; Evidence-Based Medicine; Female; Humans; Male; Parents},
	Month = {May},
	Number = {3},
	Pages = {279-86},
	Pmid = {17478580},
	Pst = {ppublish},
	Title = {Lack of evidence for increased genetic loading for autism among families of affected females: a replication from family history data in two large samples},
	Volume = {11},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1177/1362361307076857}}

@article{Jones:1988aa,
	Abstract = {Parents may respond in various ways to the birth of a seriously affected child. They may, for example, decide not to have any more children or to have one more child and then stop. These various responses are called "stoppage rules" in the genetic literature. Where stoppage rules are operative, the order in which affected and nonaffected children are born is disturbed in definite ways. The present paper shows that stoppage rules are at work in a recently reported data set consisting of 46 multiplex families of childhood autism and, as a consequence, that the segregation ratio was underestimated in the original report. The implications of these results for genetic studies of autism are then discussed.},
	Author = {Jones, M B and Szatmari, P},
	Date-Added = {2016-07-09 20:56:36 +0000},
	Date-Modified = {2016-07-09 20:56:36 +0000},
	Journal = {J Autism Dev Disord},
	Journal-Full = {Journal of autism and developmental disorders},
	Mesh = {Autistic Disorder; Birth Order; Family Characteristics; Female; Genetic Counseling; Humans; Male; Parent-Child Relations},
	Month = {Mar},
	Number = {1},
	Pages = {31-40},
	Pmid = {3372457},
	Pst = {ppublish},
	Title = {Stoppage rules and genetic studies of autism},
	Volume = {18},
	Year = {1988}}

@article{Hagberg:1983aa,
	Abstract = {Thirty-five patients, exclusively girls, from three countries had a uniform and striking progressive encephalopathy. After normal general and psychomotor development up to the age of 7 to 18 months, developmental stagnation occurred, followed by rapid deterioration of higher brain functions. Within one-and-a-half years this deterioration led to severe dementia, autism, loss of purposeful use of the hands, jerky truncal ataxia, and acquired microcephaly. The destructive stage was followed by apparent stability lasting through decades. Additional insidious neurological abnormalities supervened, mainly spastic parapareses, vasomotor disturbances of the lower limbs, and epilepsy. Prior extensive laboratory investigations have not revealed the cause. The condition is similar to a virtually overlooked syndrome described by Rett in the German literature. The exclusive involvement of females, correlated with findings in family data analyses, suggests a dominant mutation on one X chromosome that results in affected girls and nonviable male hemizygous conceptuses.},
	Author = {Hagberg, B and Aicardi, J and Dias, K and Ramos, O},
	Date-Added = {2016-07-09 20:45:08 +0000},
	Date-Modified = {2016-07-09 20:45:08 +0000},
	Doi = {10.1002/ana.410140412},
	Journal = {Ann Neurol},
	Journal-Full = {Annals of neurology},
	Mesh = {Adolescent; Adult; Ammonia; Apraxias; Ataxia; Autistic Disorder; Child; Child Development; Child, Preschool; Dementia; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Microcephaly; Motor Skills; Muscle Spasticity; Paralysis; Psychomotor Disorders; Stereotyped Behavior; Syndrome},
	Month = {Oct},
	Number = {4},
	Pages = {471-9},
	Pmid = {6638958},
	Pst = {ppublish},
	Title = {A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases},
	Volume = {14},
	Year = {1983},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/ana.410140412}}

@article{Aziz:2003aa,
	Abstract = {Fragile X syndrome has a characteristic behavioural and physical phenotype. Clinical experience and case reports suggest that boys with premutations and intermediate alleles may have similar, but possibly milder, clinical features than those with the full mutation. We conducted detailed physical, psychiatric, psychological and speech and language evaluations on a clinical series of 10 boys, with either premutation or intermediate CGG triplet expansions. Wherever possible we measured the levels of FMR1 protein in participants' hair roots. Many participants demonstrated striking resemblance in their clinical picture, behavioural and physical, to individuals with the fragile X syndrome full mutation. However, protein expression was normal in all participants where it was assessed, despite large variation in CGG triplet repeats. We propose that the findings are unlikely to be attributable to ascertainment bias alone. Replication on larger independent samples is required to confirm our impression that fragile X premutations and intermediate alleles may be associated with important developmental disabilities and physical features.},
	Author = {Aziz, Monica and Stathopulu, Eleni and Callias, Maria and Taylor, Catherine and Turk, Jeremy and Oostra, Ben and Willemsen, Rob and Patton, Mike},
	Date-Added = {2016-07-09 20:43:24 +0000},
	Date-Modified = {2016-07-09 20:43:24 +0000},
	Doi = {10.1002/ajmg.b.20030},
	Journal = {Am J Med Genet B Neuropsychiatr Genet},
	Journal-Full = {American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics},
	Mesh = {Autistic Disorder; Fragile X Mental Retardation Protein; Fragile X Syndrome; Humans; Language Development Disorders; Male; Nerve Tissue Proteins; RNA-Binding Proteins; Trinucleotide Repeat Expansion},
	Month = {Aug},
	Number = {1},
	Pages = {119-27},
	Pmid = {12898586},
	Pst = {ppublish},
	Title = {Clinical features of boys with fragile X premutations and intermediate alleles},
	Volume = {121B},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/ajmg.b.20030}}

@article{Tartaglia:2008aa,
	Abstract = {XXYY syndrome occurs in approximately 1:18,000-1:40,000 males. Although the physical phenotype is similar to 47,XXY (tall stature, hypergonadotropic hypogonadism, and infertility), XXYY is associated with additional medical problems and more significant neurodevelopmental and psychological features. We report on the results of a cross-sectional, multi-center study of 95 males age 1-55 with XXYY syndrome (mean age 14.9 years), describing diagnosis, physical features, medical problems, medications, and psychological features stratified by age groups. The mean age of diagnosis was 7.7 years. Developmental delays and behavioral problems were the most common primary indication for genetic testing (68.4%). Physical and facial features varied with age, although hypertelorism, clinodactyly, pes planus, and dental problems were common across all age groups. Tall stature was present in adolescents and adults, with a mean adult stature of 192.4 cm (SD 7.5; n = 22). Common medical problems included allergies and asthma (>50%), congenital heart defects (19.4%), radioulnar synostosis (17.2%), inguinal hernia and/or cryptorchidism (16.1%), and seizures (15%). Medical features in adulthood included hypogonadism (100%), DVT (18.2%), intention tremor (71%) and type II diabetes (18.2%). Brain MRI (n = 35) showed white matter abnormalities in 45.7% of patients and enlarged ventricles in 22.8%. Neurodevelopmental and psychological difficulties were a significant component of the behavioral phenotype, with developmental delays and learning disabilities universal but variable in severity. Twenty-six percent had full-scale IQs in the range of intellectual disability (MR), and adaptive functioning was significantly impacted with 68% with adaptive composite scores <70. Rates of neurodevelopmental disorders, including ADHD (72.2%), autism spectrum disorders (28.3%), mood disorders (46.8%), and tic disorders (18.9%), were elevated with 55.9% on psychopharmacologic medication overall. Recommendations for evaluation and treatment are summarized.},
	Author = {Tartaglia, Nicole and Davis, Shanlee and Hench, Alison and Nimishakavi, Sheela and Beauregard, Renee and Reynolds, Ann and Fenton, Laura and Albrecht, Lindsey and Ross, Judith and Visootsak, Jeannie and Hansen, Robin and Hagerman, Randi},
	Date-Added = {2016-07-09 20:41:49 +0000},
	Date-Modified = {2016-07-09 20:41:49 +0000},
	Doi = {10.1002/ajmg.a.32366},
	Journal = {Am J Med Genet A},
	Journal-Full = {American journal of medical genetics. Part A},
	Mesh = {Abnormalities, Multiple; Adolescent; Adult; Aneuploidy; Child; Child, Preschool; Chromosomes, Human, X; Chromosomes, Human, Y; Cohort Studies; Cross-Sectional Studies; Developmental Disabilities; Humans; Infant; Male; Mental Disorders; Middle Aged; Sex Chromosome Aberrations; Syndrome},
	Month = {Jun},
	Number = {12},
	Pages = {1509-22},
	Pmc = {PMC3056496},
	Pmid = {18481271},
	Pst = {ppublish},
	Title = {A new look at XXYY syndrome: medical and psychological features},
	Volume = {146A},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/ajmg.a.32366}}

@article{Reddy:2005aa,
	Abstract = {BACKGROUND: Autism is a behavioral disorder with impaired social interaction, communication, and repetitive and stereotypic behaviors. About 5-10 % of individuals with autism have 'secondary' autism in which an environmental agent, chromosome abnormality, or single gene disorder can be identified. Ninety percent have idiopathic autism and a major gene has not yet been identified. We have assessed the incidence of chromosome abnormalities and Fragile X syndrome in a population of autistic patients referred to our laboratory.
METHODS: Data was analyzed from 433 patients with autistic traits tested using chromosome analysis and/or fluorescence in situ hybridization (FISH) and/or molecular testing for fragile X syndrome by Southern and PCR methods.
RESULTS: The median age was 4 years. Sex ratio was 4.5 males to 1 female [354:79]. A chromosome (cs) abnormality was found in 14/421 [3.33 %] cases. The aberrations were: 4/14 [28%] supernumerary markers; 4/14 [28%] deletions; 1/14 [7%] duplication; 3/14 [21%] inversions; 2/14 [14%] translocations. FISH was performed on 23 cases for reasons other than to characterize a previously identified cytogenetic abnormality. All 23 cases were negative. Fragile-X testing by Southern blots and PCR analysis found 7/316 [2.2 %] with an abnormal result. The mutations detected were: a full mutation (fM) and abnormal methylation in 3 [43 %], mosaic mutations with partial methylation of variable clinical significance in 3 [43%] and a permutation carrier [14%]. The frequency of chromosome and fragile-X abnormalities appears to be within the range in reported surveys (cs 4.8-1.7%, FRAX 2-4%). Limitations of our retrospective study include paucity of behavioral diagnostic information, and a specific clinical criterion for testing.
CONCLUSIONS: Twenty-eight percent of chromosome abnormalities detected in our study were subtle; therefore a high resolution cytogenetic study with a scrutiny of 15q11.2q13, 2q37 and Xp23.3 region should be standard practice when the indication is autism. The higher incidence of mosaic fragile-X mutations with partial methylation compared to FRAXA positive population [50% vs 15-40%] suggests that faint bands and variations in the Southern band pattern may occur in autistic patients.},
	Author = {Reddy, Kavita S},
	Date-Added = {2016-07-09 20:39:04 +0000},
	Date-Modified = {2016-07-09 20:39:04 +0000},
	Doi = {10.1186/1471-2350-6-3},
	Journal = {BMC Med Genet},
	Journal-Full = {BMC medical genetics},
	Mesh = {Autistic Disorder; Child, Preschool; Chromosome Aberrations; Cytogenetic Analysis; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; Humans; Male; Molecular Epidemiology; Mutation; Nerve Tissue Proteins; RNA-Binding Proteins},
	Month = {Jan},
	Pages = {3},
	Pmc = {PMC548305},
	Pmid = {15655077},
	Pst = {epublish},
	Title = {Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder},
	Volume = {6},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/1471-2350-6-3}}

@article{Marco:2006aa,
	Abstract = {Recognized cases of autism spectrum disorders are on the rise. It is unclear whether this increase is attributable to secular trends in biological susceptibility, or to a change in diagnostic practices and recognition. One hint concerning etiological influences is the universally reported male excess (in the range of 4:1 to 10:1). Evidence suggests that genetic influences from the X chromosome play a crucial role in engendering this male vulnerability. In this review, we discuss three categories of genetic disease that highlight the importance of X-linked genes in the manifestation of an autistic phenotype: aneuploides (Turner syndrome and Klinefelter syndrome), trinucleotide expansions (Fragile X syndrome) and nucleotide mutations (Rett Syndrome, Neuroligins 3 & 4, and SLC6A8). The lessons from these diseases include an understanding of autistic features as a broad phenotype rather than as a single clinical entity, the role of multiple genes either alone or in concert with the manifestation of autistic features, and the role of epigenetic factors such as imprinting and X-inactivation in the expression of disease severity. Better understanding of the clinical phenotypes of social cognition and the molecular neurogenetics of X-linked gene disorders will certainly provide additional tools for understanding autism in the years to come.},
	Author = {Marco, Elysa J and Skuse, David H},
	Date-Added = {2016-07-09 20:32:07 +0000},
	Date-Modified = {2016-07-09 20:32:07 +0000},
	Doi = {10.1093/scan/nsl028},
	Journal = {Soc Cogn Affect Neurosci},
	Journal-Full = {Social cognitive and affective neuroscience},
	Mesh = {Autistic Disorder; Child; Child, Preschool; Chromosomes, Human, X; Cognition Disorders; Female; Genotype; Humans; Male; Methyl-CpG-Binding Protein 2; Phenotype; Point Mutation; Psychomotor Disorders; Sex Chromosomes; Sex Factors; Syndrome},
	Month = {Dec},
	Number = {3},
	Pages = {183-93},
	Pmc = {PMC2555419},
	Pmid = {18985105},
	Pst = {ppublish},
	Title = {Autism-lessons from the X chromosome},
	Volume = {1},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/scan/nsl028}}

@article{Rosenberg:2009aa,
	Abstract = {OBJECTIVES: To examine patterns of autism spectrum disorder (ASD) inheritance and other features in twin pairs by zygosity, sex, and specific ASD diagnosis.
DESIGN: Cross-sectional study.
SETTING: Internet-based autism registry for US residents.
PARTICIPANTS: Survey results from 277 twin pairs (210 dizygotic [DZ] and 67 monozygotic [MZ]) aged 18 years or younger with at least 1 affected twin.
MAIN EXPOSURES: Zygosity and sex.
OUTCOME MEASURES: Concordance within twin pairs of diagnosis, natural history, and results from standardized autism screening.
RESULTS: Pairwise ASD concordance was 31% for DZ and 88% for MZ twins. Female and male MZ twins were 100% and 86% concordant, respectively, and DZ twin pairs with at least 1 female were less likely to be concordant (20%) than were male-male DZ twin pairs (40%). The hazard ratio for ASD diagnosis of the second twin after a first-twin diagnosis was 7.48 for MZ vs DZ twins (95% confidence interval, 3.8-14.7). Affected DZ individual twins had an earlier age at first parental concern and more frequent diagnoses of intellectual disability than did MZ twins; MZ twins had a higher prevalence of bipolar disorder and Asperger syndrome and higher concordance of the latter. Results of autism screening correlated with parent-reported ASD status in more than 90% of cases.
CONCLUSIONS: Our data support greater ASD concordance in MZ vs DZ twins. Overall higher functioning, psychiatric comorbidity, and Asperger syndrome concordance among affected MZ vs DZ twins may also suggest differential heritability for different ASDs. For families in which one MZ twin is diagnosed with ASD, the second twin is unlikely to receive an ASD diagnosis after 12 months. In addition, Internet parent report of ASD status is valid.},
	Author = {Rosenberg, Rebecca E and Law, J Kiely and Yenokyan, Gayane and McGready, John and Kaufmann, Walter E and Law, Paul A},
	Date-Added = {2016-07-09 20:25:23 +0000},
	Date-Modified = {2016-07-09 20:25:23 +0000},
	Doi = {10.1001/archpediatrics.2009.98},
	Journal = {Arch Pediatr Adolesc Med},
	Journal-Full = {Archives of pediatrics \& adolescent medicine},
	Mesh = {Asperger Syndrome; Autistic Disorder; Child; Child Development Disorders, Pervasive; Comorbidity; Cross-Sectional Studies; Diseases in Twins; Female; Humans; Male; Sex Distribution; Twins, Dizygotic; Twins, Monozygotic; United States},
	Month = {Oct},
	Number = {10},
	Pages = {907-14},
	Pmid = {19805709},
	Pst = {ppublish},
	Title = {Characteristics and concordance of autism spectrum disorders among 277 twin pairs},
	Volume = {163},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1001/archpediatrics.2009.98}}

@article{Muhle:2004aa,
	Abstract = {Autism is a complex, behaviorally defined, static disorder of the immature brain that is of great concern to the practicing pediatrician because of an astonishing 556% reported increase in pediatric prevalence between 1991 and 1997, to a prevalence higher than that of spina bifida, cancer, or Down syndrome. This jump is probably attributable to heightened awareness and changing diagnostic criteria rather than to new environmental influences. Autism is not a disease but a syndrome with multiple nongenetic and genetic causes. By autism (the autistic spectrum disorders [ASDs]), we mean the wide spectrum of developmental disorders characterized by impairments in 3 behavioral domains: 1) social interaction; 2) language, communication, and imaginative play; and 3) range of interests and activities. Autism corresponds in this article to pervasive developmental disorder (PDD) of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition and International Classification of Diseases, Tenth Revision. Except for Rett syndrome--attributable in most affected individuals to mutations of the methyl-CpG-binding protein 2 (MeCP2) gene--the other PDD subtypes (autistic disorder, Asperger disorder, disintegrative disorder, and PDD Not Otherwise Specified [PDD-NOS]) are not linked to any particular genetic or nongenetic cause. Review of 2 major textbooks on autism and of papers published between 1961 and 2003 yields convincing evidence for multiple interacting genetic factors as the main causative determinants of autism. Epidemiologic studies indicate that environmental factors such as toxic exposures, teratogens, perinatal insults, and prenatal infections such as rubella and cytomegalovirus account for few cases. These studies fail to confirm that immunizations with the measles-mumps-rubella vaccine are responsible for the surge in autism. Epilepsy, the medical condition most highly associated with autism, has equally complex genetic/nongenetic (but mostly unknown) causes. Autism is frequent in tuberous sclerosis complex and fragile X syndrome, but these 2 disorders account for but a small minority of cases. Currently, diagnosable medical conditions, cytogenetic abnormalities, and single-gene defects (eg, tuberous sclerosis complex, fragile X syndrome, and other rare diseases) together account for <10% of cases. There is convincing evidence that "idiopathic" autism is a heritable disorder. Epidemiologic studies report an ASD prevalence of approximately 3 to 6/1000, with a male to female ratio of 3:1. This skewed ratio remains unexplained: despite the contribution of a few well characterized X-linked disorders, male-to-male transmission in a number of families rules out X-linkage as the prevailing mode of inheritance. The recurrence rate in siblings of affected children is approximately 2% to 8%, much higher than the prevalence rate in the general population but much lower than in single-gene diseases. Twin studies reported 60% concordance for classic autism in monozygotic (MZ) twins versus 0 in dizygotic (DZ) twins, the higher MZ concordance attesting to genetic inheritance as the predominant causative agent. Reevaluation for a broader autistic phenotype that included communication and social disorders increased concordance remarkably from 60% to 92% in MZ twins and from 0% to 10% in DZ pairs. This suggests that interactions between multiple genes cause "idiopathic" autism but that epigenetic factors and exposure to environmental modifiers may contribute to variable expression of autism-related traits. The identity and number of genes involved remain unknown. The wide phenotypic variability of the ASDs likely reflects the interaction of multiple genes within an individual's genome and the existence of distinct genes and gene combinations among those affected. There are 3 main approaches to identifying genetic loci, chromosomal regions likely to contain relevant genes: 1) whole genome screens, searching for linkage of autism to shared genetic markers in populations of multiplex families (families with >1 affected family member; 2) cytogenetic studies that may guide molecular studies by pointing to relevant inherited or de novo chromosomal abnormalities in affected individuals and their families; and 3) evaluation of candidate genes known to affect brain development in these significantly linked regions or, alternatively, linkage of candidate genes selected a priori because of their presumptive contribution to the pathogenesis of autism. Data from whole-genome screens in multiplex families suggest interactions of at least 10 genes in the causation of autism. Thus far, a putative speech and language region at 7q31-q33 seems most strongly linked to autism, with linkages to multiple other loci under investigation. Cytogenetic abnormalities at the 15q11-q13 locus are fairly frequent in people with autism, and a "chromosome 15 phenotype" was described in individuals with chromosome 15 duplications. Among other candidate genes are the FOXP2, RAY1/ST7, IMMP2L, and RELN genes at 7q22-q33 and the GABA(A) receptor subunit and UBE3A genes on chromosome 15q11-q13. Variant alleles of the serotonin transporter gene (5-HTT) on 17q11-q12 are more frequent in individuals with autism than in nonautistic populations. In addition, animal models and linkage data from genome screens implicate the oxytocin receptor at 3p25-p26. Most pediatricians will have 1 or more children with this disorder in their practices. They must diagnose ASD expeditiously because early intervention increases its effectiveness. Children with dysmorphic features, congenital anomalies, mental retardation, or family members with developmental disorders are those most likely to benefit from extensive medical testing and genetic consultation. The yield of testing is much less in high-functioning children with a normal appearance and IQ and moderate social and language impairments. Genetic counseling justifies testing, but until autism genes are identified and their functions are understood, prenatal diagnosis will exist only for the rare cases ascribable to single-gene defects or overt chromosomal abnormalities. Parents who wish to have more children must be told of their increased statistical risk. It is crucial for pediatricians to try to involve families with multiple affected members in formal research projects, as family studies are key to unraveling the causes and pathogenesis of autism. Parents need to understand that they and their affected children are the only available sources for identifying and studying the elusive genes responsible for autism. Future clinically useful insights and potential medications depend on identifying these genes and elucidating the influences of their products on brain development and physiology.},
	Author = {Muhle, Rebecca and Trentacoste, Stephanie V and Rapin, Isabelle},
	Date-Added = {2016-07-09 20:24:42 +0000},
	Date-Modified = {2016-07-09 20:24:42 +0000},
	Journal = {Pediatrics},
	Journal-Full = {Pediatrics},
	Mesh = {Autistic Disorder; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 7; Genetic Linkage; Humans},
	Month = {May},
	Number = {5},
	Pages = {e472-86},
	Pmid = {15121991},
	Pst = {ppublish},
	Title = {The genetics of autism},
	Volume = {113},
	Year = {2004}}

@article{Willsey:2013aa,
	Abstract = {Autism spectrum disorder (ASD) is a complex developmental syndrome of unknown etiology. Recent studies employing exome- and genome-wide sequencing have identified nine high-confidence ASD (hcASD) genes. Working from the hypothesis that ASD-associated mutations in these biologically pleiotropic genes will disrupt intersecting developmental processes to contribute to a common phenotype, we have attempted to identify time periods, brain regions, and cell types in which these genes converge. We have constructed coexpression networks based on the hcASD "seed" genes, leveraging a rich expression data set encompassing multiple human brain regions across human development and into adulthood. By assessing enrichment of an independent set of probable ASD (pASD) genes, derived from the same sequencing studies, we demonstrate a key point of convergence in midfetal layer 5/6 cortical projection neurons. This approach informs when, where, and in what cell types mutations in these specific genes may be productively studied to clarify ASD pathophysiology.},
	Author = {Willsey, A Jeremy and Sanders, Stephan J and Li, Mingfeng and Dong, Shan and Tebbenkamp, Andrew T and Muhle, Rebecca A and Reilly, Steven K and Lin, Leon and Fertuzinhos, Sofia and Miller, Jeremy A and Murtha, Michael T and Bichsel, Candace and Niu, Wei and Cotney, Justin and Ercan-Sencicek, A Gulhan and Gockley, Jake and Gupta, Abha R and Han, Wenqi and He, Xin and Hoffman, Ellen J and Klei, Lambertus and Lei, Jing and Liu, Wenzhong and Liu, Li and Lu, Cong and Xu, Xuming and Zhu, Ying and Mane, Shrikant M and Lein, Ed S and Wei, Liping and Noonan, James P and Roeder, Kathryn and Devlin, Bernie and Sestan, Nenad and State, Matthew W},
	Date-Added = {2016-07-09 20:04:14 +0000},
	Date-Modified = {2016-07-09 20:04:14 +0000},
	Doi = {10.1016/j.cell.2013.10.020},
	Journal = {Cell},
	Journal-Full = {Cell},
	Mesh = {Animals; Brain; Child Development Disorders, Pervasive; Exome; Female; Fetus; Gene Expression Profiling; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Mice; Mutation; Neurons; Prefrontal Cortex; Sequence Analysis, DNA},
	Month = {Nov},
	Number = {5},
	Pages = {997-1007},
	Pmc = {PMC3995413},
	Pmid = {24267886},
	Pst = {ppublish},
	Title = {Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism},
	Volume = {155},
	Year = {2013},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.cell.2013.10.020}}

@article{Williams:2005aa,
	Abstract = {The Childhood Asperger Syndrome Test (CAST) is a parental questionnaire to screen for autism spectrum conditions. In this validation study, the CAST was distributed to 1925 children aged 5-11 in mainstream Cambridgeshire schools. A sample of participants received a full diagnostic assessment, conducted blind to screen status. The sensitivity of the CAST, at a designated cut-point of 15, was 100 percent, the specificity was 97 percent and the positive predictive value was 50 percent, using the group's consensus diagnosis as the gold standard. The accuracy indices varied with the case definition used. The sensitivity of the accuracy statistics to case definition and to missing data was explored. The CAST is useful as a screening test for autism spectrum conditions in epidemiological research. There is not currently enough evidence to recommend the use of the CAST as a screening test within a public health screening programme in the general population.},
	Author = {Williams, Jo and Scott, Fiona and Stott, Carol and Allison, Carrie and Bolton, Patrick and Baron-Cohen, Simon and Brayne, Carol},
	Date-Added = {2016-07-09 20:04:07 +0000},
	Date-Modified = {2016-07-09 20:04:07 +0000},
	Doi = {10.1177/1362361305049029},
	Journal = {Autism},
	Journal-Full = {Autism : the international journal of research and practice},
	Mesh = {Asperger Syndrome; Child; Child, Preschool; Humans; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Surveys and Questionnaires},
	Month = {Feb},
	Number = {1},
	Pages = {45-68},
	Pmid = {15618262},
	Pst = {ppublish},
	Title = {The CAST (Childhood Asperger Syndrome Test): test accuracy},
	Volume = {9},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1177/1362361305049029}}

@article{Werling:2013aa,
	Abstract = {PURPOSE OF REVIEW: A strong male bias in autism spectrum disorder (ASD) prevalence has been observed with striking consistency, but no mechanism has yet to definitively account for this sex difference. This review explores the current status of epidemiological, genetic, and neuroendocrinological work addressing ASD prevalence and liability in males and females, so as to frame the major issues necessary to pursue a more complete understanding of the biological basis for sex-differential risk.
RECENT FINDINGS: Recent studies continue to report a male bias in ASD prevalence, but also suggest that sex differences in phenotypic presentation, including fewer restricted and repetitive behaviors and externalizing behavioral problems in females, may contribute to this bias. Genetic studies demonstrate that females are protected from the effects of heritable and de-novo ASD risk variants, and compelling work suggests that sex chromosomal genes and/or sex hormones, especially testosterone, may modulate the effects of genetic variation on the presentation of an autistic phenotype.
SUMMARY: ASDs affect females less frequently than males, and several sex-differential genetic and hormonal factors may contribute. Future work to determine the mechanisms by which these factors confer risk and protection to males and females is essential.},
	Author = {Werling, Donna M and Geschwind, Daniel H},
	Date-Added = {2016-07-09 20:04:00 +0000},
	Date-Modified = {2016-07-09 20:04:00 +0000},
	Doi = {10.1097/WCO.0b013e32835ee548},
	Journal = {Curr Opin Neurol},
	Journal-Full = {Current opinion in neurology},
	Mesh = {Child; Child Development Disorders, Pervasive; Female; Humans; Male; Sex Characteristics},
	Month = {Apr},
	Number = {2},
	Pages = {146-53},
	Pmc = {PMC4164392},
	Pmid = {23406909},
	Pst = {ppublish},
	Title = {Sex differences in autism spectrum disorders},
	Volume = {26},
	Year = {2013},
	Bdsk-Url-1 = {http://dx.doi.org/10.1097/WCO.0b013e32835ee548}}

@article{Virkud:2009aa,
	Abstract = {Recent research has suggested that the mode of inheritance for simplex autism (SA, one individual in the family affected) may be distinct from that for multiplex autism (MA, two or more individuals affected). Since sub clinical autistic traits have been observed in "unaffected" relatives of children with autism, we explored whether the distributions of such traits in families supported differential modes of genetic transmission for SA and MA autism. We measured patterns of familial aggregation of quantitative autistic traits (QAT) in children and parents in 80 SA families and 210 MA families, using the Social Responsiveness Scale. When considering all SA and MA siblings who scored below a uniform quantitative (clinical-level) severity threshold, MA brothers exhibited a distinct pathological shift in the distribution, compared to SA brothers (P < 0.0001). Such aggregation of QAT was also observed in fathers but not among females in MA families. Significant spousal correlations for QAT-suggestive of assortative mating-were observed in both SA and MA families, but neither group was characterized by a greater-than-chance level of concordant elevation among spousal pairs in this volunteer sample. Among male first degree relatives, there exist distinct patterns of QAT manifestation for simplex versus multiplex autism. These findings are consistent with the results of molecular genetic studies that have suggested differential modes of intergenerational transmission for SA and MA. Characterization of QAT and other endophenotypes among close relatives may be useful for reducing sample heterogeneity in future genetic and neurobiologic studies of autism.},
	Author = {Virkud, Yamini V and Todd, Richard D and Abbacchi, Anna M and Zhang, Yi and Constantino, John N},
	Date-Added = {2016-07-09 20:03:54 +0000},
	Date-Modified = {2016-07-09 20:03:54 +0000},
	Doi = {10.1002/ajmg.b.30810},
	Journal = {Am J Med Genet B Neuropsychiatr Genet},
	Journal-Full = {American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics},
	Mesh = {Autistic Disorder; Child; Child, Preschool; Family; Female; Humans; Male; Parents; Pedigree; Phenotype; Psychiatric Status Rating Scales; Quantitative Trait, Heritable; Siblings; Social Behavior},
	Month = {Apr},
	Number = {3},
	Pages = {328-34},
	Pmc = {PMC2819431},
	Pmid = {18618672},
	Pst = {ppublish},
	Title = {Familial aggregation of quantitative autistic traits in multiplex versus simplex autism},
	Volume = {150B},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/ajmg.b.30810}}

@article{Vaags:2012aa,
	Abstract = {The three members of the human neurexin gene family, neurexin 1 (NRXN1), neurexin 2 (NRXN2), and neurexin 3 (NRXN3), encode neuronal adhesion proteins that have important roles in synapse development and function. In autism spectrum disorder (ASD), as well as in other neurodevelopmental conditions, rare exonic copy-number variants and/or point mutations have been identified in the NRXN1 and NRXN2 loci. We present clinical characterization of four index cases who have been diagnosed with ASD and who possess rare inherited or de novo microdeletions at 14q24.3-31.1, a region that overlaps exons of the alpha and/or beta isoforms of NRXN3. NRXN3 deletions were found in one father with subclinical autism and in a carrier mother and father without formal ASD diagnoses, indicating issues of penetrance and expressivity at this locus. Notwithstanding these clinical complexities, this report on ASD-affected individuals who harbor NRXN3 exonic deletions advances the understanding of the genetic etiology of autism, further enabling molecular diagnoses.},
	Author = {Vaags, Andrea K and Lionel, Anath C and Sato, Daisuke and Goodenberger, McKinsey and Stein, Quinn P and Curran, Sarah and Ogilvie, Caroline and Ahn, Joo Wook and Drmic, Irene and Senman, Lili and Chrysler, Christina and Thompson, Ann and Russell, Carolyn and Prasad, Aparna and Walker, Susan and Pinto, Dalila and Marshall, Christian R and Stavropoulos, Dimitri J and Zwaigenbaum, Lonnie and Fernandez, Bridget A and Fombonne, Eric and Bolton, Patrick F and Collier, David A and Hodge, Jennelle C and Roberts, Wendy and Szatmari, Peter and Scherer, Stephen W},
	Date-Added = {2016-07-09 20:03:49 +0000},
	Date-Modified = {2016-07-09 20:03:49 +0000},
	Doi = {10.1016/j.ajhg.2011.11.025},
	Journal = {Am J Hum Genet},
	Journal-Full = {American journal of human genetics},
	Mesh = {Adolescent; Adult; Child; Child Development Disorders, Pervasive; Child, Preschool; Chromosomes, Human, Pair 14; DNA Copy Number Variations; Female; Gene Deletion; Genetic Loci; Humans; Male; Nerve Tissue Proteins; Pedigree; Penetrance; Young Adult},
	Month = {Jan},
	Number = {1},
	Pages = {133-41},
	Pmc = {PMC3257896},
	Pmid = {22209245},
	Pst = {ppublish},
	Title = {Rare deletions at the neurexin 3 locus in autism spectrum disorder},
	Volume = {90},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.ajhg.2011.11.025}}

@article{Thorisson:2005aa,
	Abstract = {The HapMap Web site at http://www.hapmap.org is the primary portal to genotype data produced as part of the International Haplotype Map Project. In phase I of the project, >1.1 million SNPs were genotyped in 270 individuals from four worldwide populations. The HapMap Web site provides researchers with a number of tools that allow them to analyze the data as well as download data for local analyses. This paper presents step-by-step guides to using those tools, including guides for retrieving genotype and frequency data, picking tag-SNPs for use in association studies, viewing haplotypes graphically, and examining marker-to-marker LD patterns.},
	Author = {Thorisson, Gudmundur A and Smith, Albert V and Krishnan, Lalitha and Stein, Lincoln D},
	Date-Added = {2016-07-09 20:03:42 +0000},
	Date-Modified = {2016-07-09 20:03:42 +0000},
	Doi = {10.1101/gr.4413105},
	Journal = {Genome Res},
	Journal-Full = {Genome research},
	Mesh = {Computational Biology; Databases, Genetic; Genome, Human; Genomics; Haplotypes; Humans; Internet},
	Month = {Nov},
	Number = {11},
	Pages = {1592-3},
	Pmc = {PMC1310647},
	Pmid = {16251469},
	Pst = {ppublish},
	Title = {The International HapMap Project Web site},
	Volume = {15},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1101/gr.4413105}}

@article{Thomas:2013aa,
	Abstract = {Proteins of the ankyrin-repeat and SOCS-box (ASB) family act as the substrate-recognition subunits of ECS-type (ElonginBC-Cullin-SOCS-box) Cullin RING E3 ubiquitin ligase (CRL) complexes that catalyze the specific polyubiquitination of cellular proteins to target them for degradation by the proteasome. Therefore, ASB multimeric complexes are involved in numerous cell processes and pathways; however, their interactions, assembly, and biological roles remain poorly understood. To enhance our understanding of ASB CRL systems, we investigated the structure, affinity, and assembly of the quaternary multisubunit complex formed by ASB9, Elongin B, Elongin C (EloBC), and Cullin 5. Here, we describe the application of several biophysical techniques including differential scanning fluorimetry, isothermal titration calorimetry (ITC), nanoelectrospray ionization, and ion-mobility mass spectrometry (IM-MS) to provide structural and thermodynamic information for a quaternary ASB CRL complex. We find that ASB9 is unstable alone but forms a stable ternary complex with EloBC that binds with high affinity to the Cullin 5 N-terminal domain (Cul5NTD) but not to Cul2NTD. The structure of the monomeric ASB9-EloBC-Cul5NTD quaternary complex is revealed by molecular modeling and is consistent with IM-MS and temperature-dependent ITC data. This is the first experimental study to validate structural information for the assembly of the quaternary N-terminal region of an ASB CRL complex. The results suggest that ASB E3 ligase complexes function and assemble in an analogous manner to that of other CRL systems and provide a platform for further molecular investigation of this important protein family. The data reported here will also be of use for the future development of chemical probes to examine the biological function and modulation of other ECS-type CRL systems.},
	Author = {Thomas, Jemima C and Matak-Vinkovic, Dijana and Van Molle, Inge and Ciulli, Alessio},
	Date-Added = {2016-07-09 20:03:34 +0000},
	Date-Modified = {2016-07-09 20:03:34 +0000},
	Doi = {10.1021/bi400758h},
	Journal = {Biochemistry},
	Journal-Full = {Biochemistry},
	Mesh = {Cullin Proteins; Humans; Models, Molecular; Multiprotein Complexes; Protein Binding; Protein Multimerization; Protein Structure, Tertiary; Suppressor of Cytokine Signaling Proteins; Transcription Factors; Ubiquitin; Ubiquitin-Protein Ligases},
	Month = {Aug},
	Number = {31},
	Pages = {5236-46},
	Pmc = {PMC3756526},
	Pmid = {23837592},
	Pst = {ppublish},
	Title = {Multimeric complexes among ankyrin-repeat and SOCS-box protein 9 (ASB9), ElonginBC, and Cullin 5: insights into the structure and assembly of ECS-type Cullin-RING E3 ubiquitin ligases},
	Volume = {52},
	Year = {2013},
	Bdsk-Url-1 = {http://dx.doi.org/10.1021/bi400758h}}

@article{Sumi:2006aa,
	Abstract = {Broad-spectrum autism, referred to as pervasive developmental disorder (PDD), may be associated with genetic factors. We examined 241 siblings in 269 Japanese families with affected children. The sibling incidence of PDD was 10.0% whereas the prevalence of PDD in the general population in the same geographic region was 2.1%. Both of these rates are higher than those reported previously, probably because of the expanded clinical criteria applied. The prevalence in males of the general population was 3.3% and that in females was 0.82%. The sibling incidences were 7.7 and 20.0% for families in which the probands were male and female, respectively. Because the reversed sex ratios correspond to the general rule for a multifactorial threshold model, we suggest that most PDD cases result from the cumulative effects of multiple factors (mostly genetic). The sibling incidences were 0 and 10.9% for families in which the proband had low and normal birth-weight, respectively, suggesting the risk is lower in families with low-birth-weight probands.},
	Author = {Sumi, Satoshi and Taniai, Hiroko and Miyachi, Taishi and Tanemura, Mitsuyo},
	Date-Added = {2016-07-09 20:03:27 +0000},
	Date-Modified = {2016-07-09 20:03:27 +0000},
	Doi = {10.1007/s10038-006-0392-7},
	Journal = {J Hum Genet},
	Journal-Full = {Journal of human genetics},
	Mesh = {Birth Order; Birth Weight; Child Development Disorders, Pervasive; Child, Preschool; Chromosomes, Human, X; Cohort Studies; Data Collection; Female; Humans; Infant; Japan; Male; Models, Genetic; Risk Factors; Sex Ratio; Siblings},
	Number = {6},
	Pages = {518-22},
	Pmid = {16565880},
	Pst = {ppublish},
	Title = {Sibling risk of pervasive developmental disorder estimated by means of an epidemiologic survey in Nagoya, Japan},
	Volume = {51},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10038-006-0392-7}}

@article{Sartori-da-Silva:2010aa,
	Abstract = {ECS (Elongin BC-Cul2/Cul5-SOCS-box protein) ubiquitin ligases recruit substrates to E2 ubiquitin-conjugating enzymes through a SOCS-box protein substrate receptor, an Elongin BC adaptor and a cullin (Cul2 or Cul5) scaffold which interacts with the RING protein. In vitro studies have shown that the conserved amino acid sequence of the cullin box in SOCS-box proteins is required for complex formation and function. However, the in vivo importance of cullin boxes has not been addressed. To explore the biological functions of the cullin box domain of ankyrin repeat and SOCS-box containing protein 11 (d-Asb11), a key mediator of canonical Delta-Notch signaling, we isolated a zebrafish mutant lacking the Cul5 box (Asb11(Cul)). We found that homozygous zebrafish mutants for this allele were defective in Notch signaling as indicated by the impaired expression of Notch target genes. Importantly, asb11(Cul) fish were not capable to degrade the Notch ligand DeltaA during embryogenesis, a process essential for the initiation of Notch signaling during neurogenesis. Accordingly, proper cell fate specification within the neurogenic regions of the zebrafish embryo was impaired. In addition, Asb11(Cul) mRNA was defective in the ability to transactivate a her4::gfp reporter DNA when injected in embryos. Thus, our study reporting the generation and the characterization of a metazoan organism mutant in the conserved cullin binding domain of the SOCS-box demonstrates a hitherto unrecognized importance of the SOCS-box domain for the function of this class of cullin-RING ubiquitin ligases and establishes that the d-Asb11 cullin box is required for both canonical Notch signaling and proper neurogenesis.},
	Author = {Sartori da Silva, Maria A and Tee, Jin-Ming and Paridaen, Judith and Brouwers, Anke and Runtuwene, Vincent and Zivkovic, Danica and Diks, Sander H and Guardavaccaro, Daniele and Peppelenbosch, Maikel P},
	Date-Added = {2016-07-09 20:03:21 +0000},
	Date-Modified = {2016-07-09 20:03:21 +0000},
	Doi = {10.1371/journal.pone.0014023},
	Journal = {PLoS One},
	Journal-Full = {PloS one},
	Mesh = {Animals; Basic Helix-Loop-Helix Transcription Factors; Binding Sites; Cell Proliferation; Cullin Proteins; Embryo, Nonmammalian; Gene Expression Regulation, Developmental; Green Fluorescent Proteins; Immunoblotting; In Situ Hybridization; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Microscopy, Confocal; Mutation; Neurons; Receptors, Notch; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Suppressor of Cytokine Signaling Proteins; Zebrafish; Zebrafish Proteins},
	Number = {11},
	Pages = {e14023},
	Pmc = {PMC2988792},
	Pmid = {21124961},
	Pst = {epublish},
	Title = {Essential role for the d-Asb11 cul5 Box domain for proper notch signaling and neural cell fate decisions in vivo},
	Volume = {5},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pone.0014023}}

@article{Sanders:2012ab,
	Abstract = {Multiple studies have confirmed the contribution of rare de novo copy number variations to the risk for autism spectrum disorders. But whereas de novo single nucleotide variants have been identified in affected individuals, their contribution to risk has yet to be clarified. Specifically, the frequency and distribution of these mutations have not been well characterized in matched unaffected controls, and such data are vital to the interpretation of de novo coding mutations observed in probands. Here we show, using whole-exome sequencing of 928 individuals, including 200 phenotypically discordant sibling pairs, that highly disruptive (nonsense and splice-site) de novo mutations in brain-expressed genes are associated with autism spectrum disorders and carry large effects. On the basis of mutation rates in unaffected individuals, we demonstrate that multiple independent de novo single nucleotide variants in the same gene among unrelated probands reliably identifies risk alleles, providing a clear path forward for gene discovery. Among a total of 279 identified de novo coding mutations, there is a single instance in probands, and none in siblings, in which two independent nonsense variants disrupt the same gene, SCN2A (sodium channel, voltage-gated, type II, Î± subunit), a result that is highly unlikely by chance.},
	Author = {Sanders, Stephan J and Murtha, Michael T and Gupta, Abha R and Murdoch, John D and Raubeson, Melanie J and Willsey, A Jeremy and Ercan-Sencicek, A Gulhan and DiLullo, Nicholas M and Parikshak, Neelroop N and Stein, Jason L and Walker, Michael F and Ober, Gordon T and Teran, Nicole A and Song, Youeun and El-Fishawy, Paul and Murtha, Ryan C and Choi, Murim and Overton, John D and Bjornson, Robert D and Carriero, Nicholas J and Meyer, Kyle A and Bilguvar, Kaya and Mane, Shrikant M and Sestan, Nenad and Lifton, Richard P and G{\"u}nel, Murat and Roeder, Kathryn and Geschwind, Daniel H and Devlin, Bernie and State, Matthew W},
	Date-Added = {2016-07-09 20:03:10 +0000},
	Date-Modified = {2016-07-09 20:03:10 +0000},
	Doi = {10.1038/nature10945},
	Journal = {Nature},
	Journal-Full = {Nature},
	Mesh = {Alleles; Autistic Disorder; Codon, Nonsense; Exome; Exons; Genetic Heterogeneity; Genetic Predisposition to Disease; Humans; Mutation; NAV1.2 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; RNA Splice Sites; Siblings; Sodium Channels},
	Month = {May},
	Number = {7397},
	Pages = {237-41},
	Pmc = {PMC3667984},
	Pmid = {22495306},
	Pst = {epublish},
	Title = {De novo mutations revealed by whole-exome sequencing are strongly associated with autism},
	Volume = {485},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature10945}}

@article{Sanders:2011aa,
	Abstract = {We have undertaken a genome-wide analysis of rare copy-number variation (CNV) in 1124 autism spectrum disorder (ASD) families, each comprised of a single proband, unaffected parents, and, in most kindreds, an unaffected sibling. We find significant association of ASD with de novo duplications of 7q11.23, where the reciprocal deletion causes Williams-Beuren syndrome, characterized by a highly social personality. We identify rare recurrent de novo CNVs at five additional regions, including 16p13.2 (encompassing genes USP7 and C16orf72) and Cadherin 13, and implement a rigorous approach to evaluating the statistical significance of these observations. Overall, large de novo CNVs, particularly those encompassing multiple genes, confer substantial risks (OR = 5.6; CI = 2.6-12.0, p = 2.4 Ã— 10(-7)). We estimate there are 130-234 ASD-related CNV regions in the human genome and present compelling evidence, based on cumulative data, for association of rare de novo events at 7q11.23, 15q11.2-13.1, 16p11.2, and Neurexin 1.},
	Author = {Sanders, Stephan J and Ercan-Sencicek, A Gulhan and Hus, Vanessa and Luo, Rui and Murtha, Michael T and Moreno-De-Luca, Daniel and Chu, Su H and Moreau, Michael P and Gupta, Abha R and Thomson, Susanne A and Mason, Christopher E and Bilguvar, Kaya and Celestino-Soper, Patricia B S and Choi, Murim and Crawford, Emily L and Davis, Lea and Wright, Nicole R Davis and Dhodapkar, Rahul M and DiCola, Michael and DiLullo, Nicholas M and Fernandez, Thomas V and Fielding-Singh, Vikram and Fishman, Daniel O and Frahm, Stephanie and Garagaloyan, Rouben and Goh, Gerald S and Kammela, Sindhuja and Klei, Lambertus and Lowe, Jennifer K and Lund, Sabata C and McGrew, Anna D and Meyer, Kyle A and Moffat, William J and Murdoch, John D and O'Roak, Brian J and Ober, Gordon T and Pottenger, Rebecca S and Raubeson, Melanie J and Song, Youeun and Wang, Qi and Yaspan, Brian L and Yu, Timothy W and Yurkiewicz, Ilana R and Beaudet, Arthur L and Cantor, Rita M and Curland, Martin and Grice, Dorothy E and G{\"u}nel, Murat and Lifton, Richard P and Mane, Shrikant M and Martin, Donna M and Shaw, Chad A and Sheldon, Michael and Tischfield, Jay A and Walsh, Christopher A and Morrow, Eric M and Ledbetter, David H and Fombonne, Eric and Lord, Catherine and Martin, Christa Lese and Brooks, Andrew I and Sutcliffe, James S and Cook, Jr, Edwin H and Geschwind, Daniel and Roeder, Kathryn and Devlin, Bernie and State, Matthew W},
	Date-Added = {2016-07-09 20:03:04 +0000},
	Date-Modified = {2016-07-09 20:03:04 +0000},
	Doi = {10.1016/j.neuron.2011.05.002},
	Journal = {Neuron},
	Journal-Full = {Neuron},
	Mesh = {Adolescent; Cadherins; Cell Adhesion Molecules, Neuronal; Child; Child Development Disorders, Pervasive; Child, Preschool; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 7; Chromosomes, Human, X; DNA Copy Number Variations; Family Health; Female; Gene Duplication; Gene Expression Profiling; Genome-Wide Association Study; Genotype; Humans; Male; Nerve Tissue Proteins; Oligonucleotide Array Sequence Analysis; Phenotype; Proteins; Siblings; Ubiquitin Thiolesterase; Williams Syndrome},
	Month = {Jun},
	Number = {5},
	Pages = {863-85},
	Pmc = {PMC3939065},
	Pmid = {21658581},
	Pst = {ppublish},
	Title = {Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism},
	Volume = {70},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.neuron.2011.05.002}}

@article{Sanders:2012aa,
	Abstract = {While a recent study has reported that early citalopram exposure alters cortical network function and produces autistic-like behaviors in male rats, when evaluating antidepressant animal models of autism spectrum disorder (ASD) it is important to note that some selective serotonin (5-HT) reuptake inhibitors alter 3Î±-hydroxysteroid dehydrogenase activity, and thus steroidogenesis. At least one study has examined the effect of repeated citalopram administration on the serum and brain concentration of testosterone (T) and its metabolites and shown that citalopram increases serum T. Several in vitro studies also suggest that sex steroid can alter 5-HT homeostasis. While research efforts have demonstrated that transgenic mice expressing the most common of multiple gain-of-function 5-HT reuptake transporter (SERT) coding variants, SERT Ala56, previously identified in children with ASD, exhibit autistic-like behaviors, elevated p38 MAPK-dependent transporter phosphorylation, enhanced 5-HT clearance rates and hyperserotonemia, a few studies provide some evidence that 5-HT may alter gonadal steroidogenesis. T, 17Î²-estradiol and synthetic estrogens are known inhibitors of AKR1C21 (BRENDA, E.C. 1.1.1.209), the epitestosterone (epiT) producing enzyme in rodents. EpiT is a naturally occurring steroid in mammals, including man. An analysis of the literature suggests that epiT may be the central mediator in the epigenetic regulation of gene expression. Over thirty years ago, it was shown that rat brain epiT production is higher in females than in males. A similar finding in humans could explain the sex differences in the incidence of autism and other brain disorders. Despite this, the role of epiT in brain development remains a long neglected area of research.},
	Author = {Sanders, Bryan K},
	Date-Added = {2016-07-09 20:02:58 +0000},
	Date-Modified = {2016-07-09 20:02:58 +0000},
	Journal = {Pharmacol Rep},
	Journal-Full = {Pharmacological reports : PR},
	Mesh = {Animals; Brain; Child; Child Development Disorders, Pervasive; Citalopram; Disease Models, Animal; Epigenesis, Genetic; Female; Genetic Predisposition to Disease; Humans; Male; Phosphorylation; Risk Factors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Uptake Inhibitors; Sex Factors; Testosterone; p38 Mitogen-Activated Protein Kinases},
	Number = {6},
	Pages = {1285-90},
	Pmid = {23406739},
	Pst = {ppublish},
	Title = {Flowers for Algernon: steroid dysgenesis, epigenetics and brain disorders},
	Volume = {64},
	Year = {2012}}

@article{Roesler:2006aa,
	Abstract = {The mammalian bombesin (BB)-like peptide gastrin-releasing peptide (GRP) stimulates cell proliferation, displays a range of neuroendocrine activities, and acts as a growth factor in the pathogenesis of several types of human cancer. Several lines of evidence have indicated that GRP and its receptor (GRPR) might also be involved in the neurochemical alterations associated with psychiatric and neurological disorders. GRP and GRPR are distributed throughout the mammalian central nervous system (CNS). Altered levels of BB-like peptides have been found in the CNS of patients with schizophrenia and Parkinson's disease. Dysfunctions in GRPR-induced cellular calcium signaling have been reported in fibroblasts from patients with Alzheimer's disease. A translocation in the GRPR gene has been associated with autism. Pharmacological and genetic studies in rodents have shown that GRPRs in brain areas such as the dorsal hippocampus and amygdala are importantly involved in regulating synaptic plasticity and aspects of behavior that might be altered in disorders such as anxiety, schizophrenia, depression, autism and dementia. Behaviors modulated by the GRPR in rodents include grooming, food intake, stereotypy, social behavior, and emotionally-motivated learning and memory. Together, these findings support the view that the GRPR should be considered a therapeutic target for a subset of CNS diseases.},
	Author = {Roesler, R and Henriques, J A P and Schwartsmann, G},
	Date-Added = {2016-07-09 20:02:53 +0000},
	Date-Modified = {2016-07-09 20:02:53 +0000},
	Journal = {CNS Neurol Disord Drug Targets},
	Journal-Full = {CNS \& neurological disorders drug targets},
	Mesh = {Animals; Behavior, Animal; Bombesin; Brain; Brain Chemistry; Brain Diseases; Gastrin-Releasing Peptide; Genetic Predisposition to Disease; Humans; Mental Disorders; Neuronal Plasticity; Receptors, Bombesin},
	Month = {Apr},
	Number = {2},
	Pages = {197-204},
	Pmid = {16611092},
	Pst = {ppublish},
	Title = {Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders},
	Volume = {5},
	Year = {2006}}

@article{Robinson:2013aa,
	Abstract = {Male preponderance in autistic behavioral impairment has been explained in terms of a hypothetical protective effect of female sex, yet little research has tested this hypothesis empirically. If females are protected, they should require greater etiologic load to manifest the same degree of impairment as males. The objective of this analysis was to examine whether greater familial etiologic load was associated with quantitative autistic impairments in females compared with males. Subjects included 3,842 dizygotic twin pairs from the Twins Early Development Study (TEDS) and 6,040 dizygotic twin pairs from the Child and Adolescent Twin Study of Sweden (CATSS). In both samples, we compared sibling autistic traits between female and male probands, who were identified as children scoring in the top 90th and 95th percentiles of the population autistic trait distributions. In both TEDS and CATSS, siblings of female probands above the 90th percentile had significantly more autistic impairments than the siblings of male probands above the 90th percentile. The siblings of female probands above the 90th percentile also had greater categorical recurrence risk in both TEDS and CATSS. Results were similar in probands above the 95th percentile. This finding, replicated across two nationally-representative samples, suggests that female sex protects girls from autistic impairments and that girls may require greater familial etiologic load to manifest the phenotype. It provides empirical support for the hypothesis of a female protective effect against autistic behavior and can be used to inform and interpret future gene finding efforts in autism spectrum disorders.},
	Author = {Robinson, Elise B and Lichtenstein, Paul and Anckars{\"a}ter, Henrik and Happ{\'e}, Francesca and Ronald, Angelica},
	Date-Added = {2016-07-09 20:02:45 +0000},
	Date-Modified = {2016-07-09 20:02:45 +0000},
	Doi = {10.1073/pnas.1211070110},
	Journal = {Proc Natl Acad Sci U S A},
	Journal-Full = {Proceedings of the National Academy of Sciences of the United States of America},
	Mesh = {Adolescent; Autistic Disorder; Female; Humans; Male; Quantitative Trait, Heritable; Sex Characteristics; Twins, Dizygotic; Twins, Monozygotic},
	Month = {Mar},
	Number = {13},
	Pages = {5258-62},
	Pmc = {PMC3612665},
	Pmid = {23431162},
	Pst = {ppublish},
	Title = {Examining and interpreting the female protective effect against autistic behavior},
	Volume = {110},
	Year = {2013},
	Bdsk-Url-1 = {http://dx.doi.org/10.1073/pnas.1211070110}}

@article{Ritvo:1989ab,
	Abstract = {The authors recently reported, in this journal, an epidemiologic survey of autism in Utah. Twenty (9.7%) of the 207 families ascertained had more than one autistic child. Analyses of these data revealed that autism is 215 times more frequent among the siblings of autistic patients than in the general population. The overall recurrence risk estimate (the chance that each sibling born after an autistic child will develop autism) is 8.6%. If the first autistic child is a male the recurrence risk estimate is 7%, and if a female 14.5%. These new recurrence risk estimates should be made available to all individuals who have autistic children and are interested in family planning.},
	Author = {Ritvo, E R and Jorde, L B and Mason-Brothers, A and Freeman, B J and Pingree, C and Jones, M B and McMahon, W M and Petersen, P B and Jenson, W R and Mo, A},
	Date-Added = {2016-07-09 20:02:39 +0000},
	Date-Modified = {2016-07-09 20:02:39 +0000},
	Doi = {10.1176/ajp.146.8.1032},
	Journal = {Am J Psychiatry},
	Journal-Full = {The American journal of psychiatry},
	Mesh = {Autistic Disorder; Birth Order; Epidemiologic Methods; Family Characteristics; Female; Genetic Counseling; Humans; Intelligence; Male; Religion; Risk Factors; Sex Ratio; Utah},
	Month = {Aug},
	Number = {8},
	Pages = {1032-6},
	Pmid = {2750975},
	Pst = {ppublish},
	Title = {The UCLA-University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling},
	Volume = {146},
	Year = {1989},
	Bdsk-Url-1 = {http://dx.doi.org/10.1176/ajp.146.8.1032}}

@article{Ritvo:1989aa,
	Abstract = {The authors conducted an epidemiologic survey in Utah using a four-level ascertainment system, blind current diagnostic assessments, and DSM-III criteria. Of 483 individuals ascertained, 241 were diagnosed as having autism. The best estimate for the prevalence rate was 4 per 10,000 population. Autism was not associated with parental education, occupation, racial origin, or religion. Sixty-six percent of the autistic subjects scored below 70 on standardized IQ tests, and females scored proportionately lower than males. Twenty (9.7%) of 207 families had more than one autistic sibling, which supports the authors' previous finding that there may be a familial subtype of autism.},
	Author = {Ritvo, E R and Freeman, B J and Pingree, C and Mason-Brothers, A and Jorde, L and Jenson, W R and McMahon, W M and Petersen, P B and Mo, A and Ritvo, A},
	Date-Added = {2016-07-09 20:02:34 +0000},
	Date-Modified = {2016-07-09 20:02:34 +0000},
	Doi = {10.1176/ajp.146.2.194},
	Journal = {Am J Psychiatry},
	Journal-Full = {The American journal of psychiatry},
	Mesh = {Adolescent; Adult; Autistic Disorder; Child; Child, Preschool; Cross-Sectional Studies; Educational Status; Ethnic Groups; Female; Humans; Intelligence; Male; Occupations; Parents; Religion; Sex Factors; Social Class; Utah},
	Month = {Feb},
	Number = {2},
	Pages = {194-9},
	Pmid = {2783539},
	Pst = {ppublish},
	Title = {The UCLA-University of Utah epidemiologic survey of autism: prevalence},
	Volume = {146},
	Year = {1989},
	Bdsk-Url-1 = {http://dx.doi.org/10.1176/ajp.146.2.194}}

@article{Purcell:2007aa,
	Abstract = {Whole-genome association studies (WGAS) bring new computational, as well as analytic, challenges to researchers. Many existing genetic-analysis tools are not designed to handle such large data sets in a convenient manner and do not necessarily exploit the new opportunities that whole-genome data bring. To address these issues, we developed PLINK, an open-source C/C++ WGAS tool set. With PLINK, large data sets comprising hundreds of thousands of markers genotyped for thousands of individuals can be rapidly manipulated and analyzed in their entirety. As well as providing tools to make the basic analytic steps computationally efficient, PLINK also supports some novel approaches to whole-genome data that take advantage of whole-genome coverage. We introduce PLINK and describe the five main domains of function: data management, summary statistics, population stratification, association analysis, and identity-by-descent estimation. In particular, we focus on the estimation and use of identity-by-state and identity-by-descent information in the context of population-based whole-genome studies. This information can be used to detect and correct for population stratification and to identify extended chromosomal segments that are shared identical by descent between very distantly related individuals. Analysis of the patterns of segmental sharing has the potential to map disease loci that contain multiple rare variants in a population-based linkage analysis.},
	Author = {Purcell, Shaun and Neale, Benjamin and Todd-Brown, Kathe and Thomas, Lori and Ferreira, Manuel A R and Bender, David and Maller, Julian and Sklar, Pamela and de Bakker, Paul I W and Daly, Mark J and Sham, Pak C},
	Date-Added = {2016-07-09 20:02:29 +0000},
	Date-Modified = {2016-07-09 20:02:29 +0000},
	Doi = {10.1086/519795},
	Journal = {Am J Hum Genet},
	Journal-Full = {American journal of human genetics},
	Mesh = {Genetic Linkage; Genome, Human; Humans; Polymorphism, Single Nucleotide; Population; Software},
	Month = {Sep},
	Number = {3},
	Pages = {559-75},
	Pmc = {PMC1950838},
	Pmid = {17701901},
	Pst = {ppublish},
	Title = {PLINK: a tool set for whole-genome association and population-based linkage analyses},
	Volume = {81},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1086/519795}}

@article{Presti-Torres:2007aa,
	Abstract = {The gastrin-releasing peptide receptor (GRPR) has been implicated in central nervous system (CNS) diseases, including neurodevelopmental disorders associated with autism. In the present study we examined the effects of GRPR blockade during the neonatal period on behavioral measures relevant to animal models of neurodevelopmental disorders. Male Wistar rats were given an intraperitoneal (i.p.) injection of either saline (SAL) or the GRPR antagonist [D-Tpi(6), Leu(13) psi(CH(2)NH)-Leu(14)] bombesin (6-14) (RC-3095; 1 or 10mg/kg) twice daily for 10days from postnatal days (PN) 1 to 10. Animals treated with RC-3095 showed pronounced deficits in social interaction when tested at PN 30-35 and impaired 24-h retention of memory for both novel object recognition (NOR) and inhibitory avoidance (IA) tasks tested at PN 60-71. Neither short-term memory tested 1.5h posttraining nor open field behavior were affected by neonatal GRPR blockade. The implications of the findings for animal models of neurodevelopmental disorders are discussed.},
	Author = {Presti-Torres, J and de Lima, M N and Scalco, F S and Caldana, F and Garcia, V A and Guimar{\~a}es, M R and Schwartsmann, G and Roesler, Rafael and Schr{\"o}der, Nadja},
	Date-Added = {2016-07-09 20:02:23 +0000},
	Date-Modified = {2016-07-09 20:02:23 +0000},
	Doi = {10.1016/j.neuropharm.2006.09.020},
	Journal = {Neuropharmacology},
	Journal-Full = {Neuropharmacology},
	Mesh = {Age Factors; Animals; Animals, Newborn; Avoidance Learning; Body Weight; Bombesin; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Inhibition (Psychology); Injections, Intraperitoneal; Locomotion; Male; Memory Disorders; Motor Activity; Peptide Fragments; Pregnancy; Rats; Rats, Wistar; Receptors, Bombesin; Social Behavior Disorders},
	Month = {Mar},
	Number = {3},
	Pages = {724-32},
	Pmid = {17097693},
	Pst = {ppublish},
	Title = {Impairments of social behavior and memory after neonatal gastrin-releasing peptide receptor blockade in rats: Implications for an animal model of neurodevelopmental disorders},
	Volume = {52},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.neuropharm.2006.09.020}}

@article{Pinto:2014aa,
	Abstract = {Rare copy-number variation (CNV) is an important source of risk for autism spectrum disorders (ASDs). We analyzed 2,446 ASD-affected families and confirmed an excess of genic deletions and duplications in affected versus control groups (1.41-fold, p = 1.0 Ã— 10(-5)) and an increase in affected subjects carrying exonic pathogenic CNVs overlapping known loci associated with dominant or X-linked ASD and intellectual disability (odds ratio = 12.62, p = 2.7 Ã— 10(-15), âˆ¼3% of ASD subjects). Pathogenic CNVs, often showing variable expressivity, included rare de novo and inherited events at 36 loci, implicating ASD-associated genes (CHD2, HDAC4, and GDI1) previously linked to other neurodevelopmental disorders, as well as other genes such as SETD5, MIR137, and HDAC9. Consistent with hypothesized gender-specific modulators, females with ASD were more likely to have highly penetrant CNVs (p = 0.017) and were also overrepresented among subjects with fragile X syndrome protein targets (p = 0.02). Genes affected by de novo CNVs and/or loss-of-function single-nucleotide variants converged on networks related to neuronal signaling and development, synapse function, and chromatin regulation.},
	Author = {Pinto, Dalila and Delaby, Elsa and Merico, Daniele and Barbosa, Mafalda and Merikangas, Alison and Klei, Lambertus and Thiruvahindrapuram, Bhooma and Xu, Xiao and Ziman, Robert and Wang, Zhuozhi and Vorstman, Jacob A S and Thompson, Ann and Regan, Regina and Pilorge, Marion and Pellecchia, Giovanna and Pagnamenta, Alistair T and Oliveira, B{\'a}rbara and Marshall, Christian R and Magalhaes, Tiago R and Lowe, Jennifer K and Howe, Jennifer L and Griswold, Anthony J and Gilbert, John and Duketis, Eftichia and Dombroski, Beth A and De Jonge, Maretha V and Cuccaro, Michael and Crawford, Emily L and Correia, Catarina T and Conroy, Judith and Concei{\c c}{\~a}o, In{\^e}s C and Chiocchetti, Andreas G and Casey, Jillian P and Cai, Guiqing and Cabrol, Christelle and Bolshakova, Nadia and Bacchelli, Elena and Anney, Richard and Gallinger, Steven and Cotterchio, Michelle and Casey, Graham and Zwaigenbaum, Lonnie and Wittemeyer, Kerstin and Wing, Kirsty and Wallace, Simon and van Engeland, Herman and Tryfon, Ana and Thomson, Susanne and Soorya, Latha and Rog{\'e}, Bernadette and Roberts, Wendy and Poustka, Fritz and Mouga, Susana and Minshew, Nancy and McInnes, L Alison and McGrew, Susan G and Lord, Catherine and Leboyer, Marion and Le Couteur, Ann S and Kolevzon, Alexander and Jim{\'e}nez Gonz{\'a}lez, Patricia and Jacob, Suma and Holt, Richard and Guter, Stephen and Green, Jonathan and Green, Andrew and Gillberg, Christopher and Fernandez, Bridget A and Duque, Frederico and Delorme, Richard and Dawson, Geraldine and Chaste, Pauline and Caf{\'e}, C{\'a}tia and Brennan, Sean and Bourgeron, Thomas and Bolton, Patrick F and B{\"o}lte, Sven and Bernier, Raphael and Baird, Gillian and Bailey, Anthony J and Anagnostou, Evdokia and Almeida, Joana and Wijsman, Ellen M and Vieland, Veronica J and Vicente, Astrid M and Schellenberg, Gerard D and Pericak-Vance, Margaret and Paterson, Andrew D and Parr, Jeremy R and Oliveira, Guiomar and Nurnberger, John I and Monaco, Anthony P and Maestrini, Elena and Klauck, Sabine M and Hakonarson, Hakon and Haines, Jonathan L and Geschwind, Daniel H and Freitag, Christine M and Folstein, Susan E and Ennis, Sean and Coon, Hilary and Battaglia, Agatino and Szatmari, Peter and Sutcliffe, James S and Hallmayer, Joachim and Gill, Michael and Cook, Edwin H and Buxbaum, Joseph D and Devlin, Bernie and Gallagher, Louise and Betancur, Catalina and Scherer, Stephen W},
	Date-Added = {2016-07-09 20:02:16 +0000},
	Date-Modified = {2016-07-09 20:02:16 +0000},
	Doi = {10.1016/j.ajhg.2014.03.018},
	Journal = {Am J Hum Genet},
	Journal-Full = {American journal of human genetics},
	Mesh = {Child; Child Development Disorders, Pervasive; DNA Copy Number Variations; Female; Gene Regulatory Networks; Humans; Male; Metabolic Networks and Pathways; Multigene Family; Pedigree; Sequence Deletion},
	Month = {May},
	Number = {5},
	Pages = {677-94},
	Pmc = {PMC4067558},
	Pmid = {24768552},
	Pst = {ppublish},
	Title = {Convergence of genes and cellular pathways dysregulated in autism spectrum disorders},
	Volume = {94},
	Year = {2014},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.ajhg.2014.03.018}}

@article{Ozonoff:2011aa,
	Abstract = {OBJECTIVE: The recurrence risk of autism spectrum disorders (ASD) is estimated to be between 3% and 10%, but previous research was limited by small sample sizes and biases related to ascertainment, reporting, and stoppage factors. This study used prospective methods to obtain an updated estimate of sibling recurrence risk for ASD.
METHODS: A prospective longitudinal study of infants at risk for ASD was conducted by a multisite international network, the Baby Siblings Research Consortium. Infants (n = 664) with an older biological sibling with ASD were followed from early in life to 36 months, when they were classified as having or not having ASD. An ASD classification required surpassing the cutoff of the Autism Diagnostic Observation Schedule and receiving a clinical diagnosis from an expert clinician.
RESULTS: A total of 18.7% of the infants developed ASD. Infant gender and the presence of >1 older affected sibling were significant predictors of ASD outcome, and there was an almost threefold increase in risk for male subjects and an additional twofold increase in risk if there was >1 older affected sibling. The age of the infant at study enrollment, the gender and functioning level of the infant's older sibling, and other demographic factors did not predict ASD outcome.
CONCLUSIONS: The sibling recurrence rate of ASD is higher than suggested by previous estimates. The size of the current sample and prospective nature of data collection minimized many limitations of previous studies of sibling recurrence. Clinical implications, including genetic counseling, are discussed.},
	Author = {Ozonoff, Sally and Young, Gregory S and Carter, Alice and Messinger, Daniel and Yirmiya, Nurit and Zwaigenbaum, Lonnie and Bryson, Susan and Carver, Leslie J and Constantino, John N and Dobkins, Karen and Hutman, Ted and Iverson, Jana M and Landa, Rebecca and Rogers, Sally J and Sigman, Marian and Stone, Wendy L},
	Date-Added = {2016-07-09 20:02:09 +0000},
	Date-Modified = {2016-07-09 20:02:09 +0000},
	Doi = {10.1542/peds.2010-2825},
	Journal = {Pediatrics},
	Journal-Full = {Pediatrics},
	Mesh = {Child Development Disorders, Pervasive; Family Health; Female; Humans; Infant; Linear Models; Male; Recurrence; Siblings},
	Month = {Sep},
	Number = {3},
	Pages = {e488-95},
	Pmc = {PMC3164092},
	Pmid = {21844053},
	Pst = {ppublish},
	Title = {Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study},
	Volume = {128},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1542/peds.2010-2825}}

@article{ORoak:2012ab,
	Abstract = {It is well established that autism spectrum disorders (ASD) have a strong genetic component; however, for at least 70% of cases, the underlying genetic cause is unknown. Under the hypothesis that de novo mutations underlie a substantial fraction of the risk for developing ASD in families with no previous history of ASD or related phenotypes--so-called sporadic or simplex families--we sequenced all coding regions of the genome (the exome) for parent-child trios exhibiting sporadic ASD, including 189 new trios and 20 that were previously reported. Additionally, we also sequenced the exomes of 50 unaffected siblings corresponding to these new (n = 31) and previously reported trios (n = 19), for a total of 677 individual exomes from 209 families. Here we show that de novo point mutations are overwhelmingly paternal in origin (4:1 bias) and positively correlated with paternal age, consistent with the modest increased risk for children of older fathers to develop ASD. Moreover, 39% (49 of 126) of the most severe or disruptive de novo mutations map to a highly interconnected Î²-catenin/chromatin remodelling protein network ranked significantly for autism candidate genes. In proband exomes, recurrent protein-altering mutations were observed in two genes: CHD8 and NTNG1. Mutation screening of six candidate genes in 1,703 ASD probands identified additional de novo, protein-altering mutations in GRIN2B, LAMC3 and SCN1A. Combined with copy number variant (CNV) data, these results indicate extreme locus heterogeneity but also provide a target for future discovery, diagnostics and therapeutics.},
	Author = {O'Roak, Brian J and Vives, Laura and Girirajan, Santhosh and Karakoc, Emre and Krumm, Niklas and Coe, Bradley P and Levy, Roie and Ko, Arthur and Lee, Choli and Smith, Joshua D and Turner, Emily H and Stanaway, Ian B and Vernot, Benjamin and Malig, Maika and Baker, Carl and Reilly, Beau and Akey, Joshua M and Borenstein, Elhanan and Rieder, Mark J and Nickerson, Deborah A and Bernier, Raphael and Shendure, Jay and Eichler, Evan E},
	Date-Added = {2016-07-09 20:02:04 +0000},
	Date-Modified = {2016-07-09 20:02:04 +0000},
	Doi = {10.1038/nature10989},
	Journal = {Nature},
	Journal-Full = {Nature},
	Mesh = {Autistic Disorder; DNA-Binding Proteins; Exome; Exons; GPI-Linked Proteins; Genetic Predisposition to Disease; Humans; Laminin; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Parents; Point Mutation; Protein Interaction Maps; Receptors, N-Methyl-D-Aspartate; Reproducibility of Results; Siblings; Signal Transduction; Sodium Channels; Stochastic Processes; Transcription Factors; Tumor Suppressor Protein p53; beta Catenin},
	Month = {May},
	Number = {7397},
	Pages = {246-50},
	Pmc = {PMC3350576},
	Pmid = {22495309},
	Pst = {epublish},
	Title = {Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations},
	Volume = {485},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature10989}}

@article{ORoak:2012aa,
	Abstract = {Exome sequencing studies of autism spectrum disorders (ASDs) have identified many de novo mutations but few recurrently disrupted genes. We therefore developed a modified molecular inversion probe method enabling ultra-low-cost candidate gene resequencing in very large cohorts. To demonstrate the power of this approach, we captured and sequenced 44 candidate genes in 2446 ASD probands. We discovered 27 de novo events in 16 genes, 59% of which are predicted to truncate proteins or disrupt splicing. We estimate that recurrent disruptive mutations in six genes-CHD8, DYRK1A, GRIN2B, TBR1, PTEN, and TBL1XR1-may contribute to 1% of sporadic ASDs. Our data support associations between specific genes and reciprocal subphenotypes (CHD8-macrocephaly and DYRK1A-microcephaly) and replicate the importance of a Î²-catenin-chromatin-remodeling network to ASD etiology.},
	Author = {O'Roak, Brian J and Vives, Laura and Fu, Wenqing and Egertson, Jarrett D and Stanaway, Ian B and Phelps, Ian G and Carvill, Gemma and Kumar, Akash and Lee, Choli and Ankenman, Katy and Munson, Jeff and Hiatt, Joseph B and Turner, Emily H and Levy, Roie and O'Day, Diana R and Krumm, Niklas and Coe, Bradley P and Martin, Beth K and Borenstein, Elhanan and Nickerson, Deborah A and Mefford, Heather C and Doherty, Dan and Akey, Joshua M and Bernier, Raphael and Eichler, Evan E and Shendure, Jay},
	Date-Added = {2016-07-09 20:01:57 +0000},
	Date-Modified = {2016-07-09 20:01:57 +0000},
	Doi = {10.1126/science.1227764},
	Journal = {Science},
	Journal-Full = {Science (New York, N.Y.)},
	Mesh = {Cephalometry; Child; Child Development Disorders, Pervasive; Child, Preschool; Chromatin Assembly and Disassembly; Cohort Studies; DNA Probes; DNA-Binding Proteins; Exome; Female; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Megalencephaly; Microcephaly; Mutation; Nuclear Proteins; PTEN Phosphohydrolase; Protein-Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Cytoplasmic and Nuclear; Receptors, N-Methyl-D-Aspartate; Repressor Proteins; Sequence Analysis, DNA; T-Box Domain Proteins; Transcription Factors; beta Catenin},
	Month = {Dec},
	Number = {6114},
	Pages = {1619-22},
	Pmc = {PMC3528801},
	Pmid = {23160955},
	Pst = {ppublish},
	Title = {Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders},
	Volume = {338},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1126/science.1227764}}

@article{Neale:2012aa,
	Abstract = {Autism spectrum disorders (ASD) are believed to have genetic and environmental origins, yet in only a modest fraction of individuals can specific causes be identified. To identify further genetic risk factors, here we assess the role of de novo mutations in ASD by sequencing the exomes of ASD cases and their parents (n = 175 trios). Fewer than half of the cases (46.3%) carry a missense or nonsense de novo variant, and the overall rate of mutation is only modestly higher than the expected rate. In contrast, the proteins encoded by genes that harboured de novo missense or nonsense mutations showed a higher degree of connectivity among themselves and to previous ASD genes as indexed by protein-protein interaction screens. The small increase in the rate of de novo events, when taken together with the protein interaction results, are consistent with an important but limited role for de novo point mutations in ASD, similar to that documented for de novo copy number variants. Genetic models incorporating these data indicate that most of the observed de novo events are unconnected to ASD; those that do confer risk are distributed across many genes and are incompletely penetrant (that is, not necessarily sufficient for disease). Our results support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold. Despite the challenge posed by such models, results from de novo events and a large parallel case-control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors.},
	Author = {Neale, Benjamin M and Kou, Yan and Liu, Li and Ma'ayan, Avi and Samocha, Kaitlin E and Sabo, Aniko and Lin, Chiao-Feng and Stevens, Christine and Wang, Li-San and Makarov, Vladimir and Polak, Paz and Yoon, Seungtai and Maguire, Jared and Crawford, Emily L and Campbell, Nicholas G and Geller, Evan T and Valladares, Otto and Schafer, Chad and Liu, Han and Zhao, Tuo and Cai, Guiqing and Lihm, Jayon and Dannenfelser, Ruth and Jabado, Omar and Peralta, Zuleyma and Nagaswamy, Uma and Muzny, Donna and Reid, Jeffrey G and Newsham, Irene and Wu, Yuanqing and Lewis, Lora and Han, Yi and Voight, Benjamin F and Lim, Elaine and Rossin, Elizabeth and Kirby, Andrew and Flannick, Jason and Fromer, Menachem and Shakir, Khalid and Fennell, Tim and Garimella, Kiran and Banks, Eric and Poplin, Ryan and Gabriel, Stacey and DePristo, Mark and Wimbish, Jack R and Boone, Braden E and Levy, Shawn E and Betancur, Catalina and Sunyaev, Shamil and Boerwinkle, Eric and Buxbaum, Joseph D and Cook, Jr, Edwin H and Devlin, Bernie and Gibbs, Richard A and Roeder, Kathryn and Schellenberg, Gerard D and Sutcliffe, James S and Daly, Mark J},
	Date-Added = {2016-07-09 20:01:47 +0000},
	Date-Modified = {2016-07-09 20:01:47 +0000},
	Doi = {10.1038/nature11011},
	Journal = {Nature},
	Journal-Full = {Nature},
	Mesh = {Autistic Disorder; Case-Control Studies; DNA-Binding Proteins; Exome; Exons; Family Health; Genetic Predisposition to Disease; Humans; Models, Genetic; Multifactorial Inheritance; Mutation; Phenotype; Poisson Distribution; Protein Interaction Maps; Transcription Factors},
	Month = {May},
	Number = {7397},
	Pages = {242-5},
	Pmc = {PMC3613847},
	Pmid = {22495311},
	Pst = {epublish},
	Title = {Patterns and rates of exonic de novo mutations in autism spectrum disorders},
	Volume = {485},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature11011}}

@article{Liu:2014aa,
	Abstract = {BACKGROUND: De novo loss-of-function (dnLoF) mutations are found twofold more often in autism spectrum disorder (ASD) probands than their unaffected siblings. Multiple independent dnLoF mutations in the same gene implicate the gene in risk and hence provide a systematic, albeit arduous, path forward for ASD genetics. It is likely that using additional non-genetic data will enhance the ability to identify ASD genes.
METHODS: To accelerate the search for ASD genes, we developed a novel algorithm, DAWN, to model two kinds of data: rare variations from exome sequencing and gene co-expression in the mid-fetal prefrontal and motor-somatosensory neocortex, a critical nexus for risk. The algorithm casts the ensemble data as a hidden Markov random field in which the graph structure is determined by gene co-expression and it combines these interrelationships with node-specific observations, namely gene identity, expression, genetic data and the estimated effect on risk.
RESULTS: Using currently available genetic data and a specific developmental time period for gene co-expression, DAWN identified 127 genes that plausibly affect risk, and a set of likely ASD subnetworks. Validation experiments making use of published targeted resequencing results demonstrate its efficacy in reliably predicting ASD genes. DAWN also successfully predicts known ASD genes, not included in the genetic data used to create the model.
CONCLUSIONS: Validation studies demonstrate that DAWN is effective in predicting ASD genes and subnetworks by leveraging genetic and gene expression data. The findings reported here implicate neurite extension and neuronal arborization as risks for ASD. Using DAWN on emerging ASD sequence data and gene expression data from other brain regions and tissues would likely identify novel ASD genes. DAWN can also be used for other complex disorders to identify genes and subnetworks in those disorders.},
	Author = {Liu, Li and Lei, Jing and Sanders, Stephan J and Willsey, Arthur Jeremy and Kou, Yan and Cicek, Abdullah Ercument and Klei, Lambertus and Lu, Cong and He, Xin and Li, Mingfeng and Muhle, Rebecca A and Ma'ayan, Avi and Noonan, James P and Sestan, Nenad and McFadden, Kathryn A and State, Matthew W and Buxbaum, Joseph D and Devlin, Bernie and Roeder, Kathryn},
	Date-Added = {2016-07-09 20:01:39 +0000},
	Date-Modified = {2016-07-09 20:01:39 +0000},
	Doi = {10.1186/2040-2392-5-22},
	Journal = {Mol Autism},
	Journal-Full = {Molecular autism},
	Number = {1},
	Pages = {22},
	Pmc = {PMC4016412},
	Pmid = {24602502},
	Pst = {epublish},
	Title = {DAWN: a framework to identify autism genes and subnetworks using gene expression and genetics},
	Volume = {5},
	Year = {2014},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/2040-2392-5-22}}

@article{Lim:2013aa,
	Abstract = {To characterize the role of rare complete human knockouts in autism spectrum disorders (ASDs), we identify genes with homozygous or compound heterozygous loss-of-function (LoF) variants (defined as nonsense and essential splice sites) from exome sequencing of 933 cases and 869 controls. We identify a 2-fold increase in complete knockouts of autosomal genes with low rates of LoF variation (â‰¤ 5% frequency) in cases and estimate a 3% contribution to ASD risk by these events, confirming this observation in an independent set of 563 probands and 4,605 controls. Outside the pseudoautosomal regions on the X chromosome, we similarly observe a significant 1.5-fold increase in rare hemizygous knockouts in males, contributing to another 2% of ASDs in males. Taken together, these results provide compelling evidence that rare autosomal and X chromosome complete gene knockouts are important inherited risk factors for ASD.},
	Author = {Lim, Elaine T and Raychaudhuri, Soumya and Sanders, Stephan J and Stevens, Christine and Sabo, Aniko and MacArthur, Daniel G and Neale, Benjamin M and Kirby, Andrew and Ruderfer, Douglas M and Fromer, Menachem and Lek, Monkol and Liu, Li and Flannick, Jason and Ripke, Stephan and Nagaswamy, Uma and Muzny, Donna and Reid, Jeffrey G and Hawes, Alicia and Newsham, Irene and Wu, Yuanqing and Lewis, Lora and Dinh, Huyen and Gross, Shannon and Wang, Li-San and Lin, Chiao-Feng and Valladares, Otto and Gabriel, Stacey B and dePristo, Mark and Altshuler, David M and Purcell, Shaun M and {NHLBI Exome Sequencing Project} and State, Matthew W and Boerwinkle, Eric and Buxbaum, Joseph D and Cook, Edwin H and Gibbs, Richard A and Schellenberg, Gerard D and Sutcliffe, James S and Devlin, Bernie and Roeder, Kathryn and Daly, Mark J},
	Date-Added = {2016-07-09 20:01:33 +0000},
	Date-Modified = {2016-07-09 20:01:33 +0000},
	Doi = {10.1016/j.neuron.2012.12.029},
	Journal = {Neuron},
	Journal-Full = {Neuron},
	Mesh = {Case-Control Studies; Child Development Disorders, Pervasive; Child, Preschool; Chromosomes, Human, X; Demography; Female; Gene Deletion; Genetic Variation; Homozygote; Humans; Linkage Disequilibrium; Loss of Heterozygosity; Male; Risk Factors},
	Month = {Jan},
	Number = {2},
	Pages = {235-42},
	Pmc = {PMC3613849},
	Pmid = {23352160},
	Pst = {ppublish},
	Title = {Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders},
	Volume = {77},
	Year = {2013},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.neuron.2012.12.029}}

@article{Li:2008aa,
	Abstract = {Hidden population substructure can cause population stratification and lead to false-positive findings in population-based genome-wide association (GWA) studies. Given a large panel of markers scanned in a GWA study, it becomes increasingly feasible to uncover the hidden population substructure within the study sample based on measured genotypes across the genome. Recognizing that population substructure can be displayed as clustered and/or continuous patterns of genetic variation, we propose a method that aims at the detection and correction of the confounding effect resulting from both patterns of population substructure. The proposed method is an extension of the EIGENSTRAT method (Price et al. [2006] Nat Genet 38:904-909). This approach is computationally feasible and easily applied to large-scale GWA studies. We show through simulation studies that, compared with the EIGENSTRAT method, the new method requires a smaller number of markers and yields a more appropriate correction for population stratification.},
	Author = {Li, Qizhai and Yu, Kai},
	Date-Added = {2016-07-09 20:01:24 +0000},
	Date-Modified = {2016-07-09 20:01:24 +0000},
	Doi = {10.1002/gepi.20296},
	Journal = {Genet Epidemiol},
	Journal-Full = {Genetic epidemiology},
	Mesh = {Cluster Analysis; Computer Simulation; Databases, Genetic; Genetic Markers; Genetic Predisposition to Disease; Genetics, Population; Genome, Human; Humans; Models, Genetic; Polymorphism, Single Nucleotide},
	Month = {Apr},
	Number = {3},
	Pages = {215-26},
	Pmid = {18161052},
	Pst = {ppublish},
	Title = {Improved correction for population stratification in genome-wide association studies by identifying hidden population structures},
	Volume = {32},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/gepi.20296}}

@article{Levy:2011aa,
	Abstract = {To explore the genetic contribution to autistic spectrum disorders (ASDs), we have studied genomic copy-number variation in a large cohort of families with a single affected child and at least one unaffected sibling. We confirm a major contribution from de novo deletions and duplications but also find evidence of a role for inherited "ultrarare" duplications. Our results show that, relative to males, females have greater resistance to autism from genetic causes, which raises the question of the fate of female carriers. By analysis of the proportion and number of recurrent loci, we set a lower bound for distinct target loci at several hundred. We find many new candidate regions, adding substantially to the list of potential gene targets, and confirm several loci previously observed. The functions of the genes in the regions of de novo variation point to a great diversity of genetic causes but also suggest functional convergence.},
	Author = {Levy, Dan and Ronemus, Michael and Yamrom, Boris and Lee, Yoon-ha and Leotta, Anthony and Kendall, Jude and Marks, Steven and Lakshmi, B and Pai, Deepa and Ye, Kenny and Buja, Andreas and Krieger, Abba and Yoon, Seungtai and Troge, Jennifer and Rodgers, Linda and Iossifov, Ivan and Wigler, Michael},
	Date-Added = {2016-07-09 20:01:17 +0000},
	Date-Modified = {2016-07-09 20:01:17 +0000},
	Doi = {10.1016/j.neuron.2011.05.015},
	Journal = {Neuron},
	Journal-Full = {Neuron},
	Mesh = {Child; Child Development Disorders, Pervasive; Child, Preschool; DNA Copy Number Variations; Databases, Nucleic Acid; Family Health; Female; Gene Deletion; Gene Expression Profiling; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Models, Statistical; Neurotransmitter Agents; Oligonucleotide Array Sequence Analysis; Phenotype; Probability; Siblings},
	Month = {Jun},
	Number = {5},
	Pages = {886-97},
	Pmid = {21658582},
	Pst = {ppublish},
	Title = {Rare de novo and transmitted copy-number variation in autistic spectrum disorders},
	Volume = {70},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.neuron.2011.05.015}}

@article{Laumonnier:2004aa,
	Abstract = {A large French family including members affected by nonspecific X-linked mental retardation, with or without autism or pervasive developmental disorder in affected male patients, has been found to have a 2-base-pair deletion in the Neuroligin 4 gene (NLGN4) located at Xp22.33. This mutation leads to a premature stop codon in the middle of the sequence of the normal protein and is thought to suppress the transmembrane domain and sequences important for the dimerization of neuroligins that are required for proper cell-cell interaction through binding to beta-neurexins. As the neuroligins are mostly enriched at excitatory synapses, these results suggest that a defect in synaptogenesis may lead to deficits in cognitive development and communication processes. The fact that the deletion was present in both autistic and nonautistic mentally retarded males suggests that the NLGN4 gene is not only involved in autism, as previously described, but also in mental retardation, indicating that some types of autistic disorder and mental retardation may have common genetic origins.},
	Author = {Laumonnier, Fr{\'e}d{\'e}ric and Bonnet-Brilhault, Fr{\'e}d{\'e}rique and Gomot, Marie and Blanc, Romuald and David, Albert and Moizard, Marie-Pierre and Raynaud, Martine and Ronce, Nathalie and Lemonnier, Eric and Calvas, Patrick and Laudier, B{\'e}atrice and Chelly, Jamel and Fryns, Jean-Pierre and Ropers, Hans-Hilger and Hamel, Ben C J and Andres, Christian and Barth{\'e}l{\'e}my, Catherine and Moraine, Claude and Briault, Sylvain},
	Date-Added = {2016-07-09 20:01:11 +0000},
	Date-Modified = {2016-07-09 20:01:11 +0000},
	Doi = {10.1086/382137},
	Journal = {Am J Hum Genet},
	Journal-Full = {American journal of human genetics},
	Mesh = {Adolescent; Adult; Autistic Disorder; Carrier Proteins; Cell Adhesion Molecules, Neuronal; Child; Child, Preschool; Female; Genetic Linkage; Humans; Male; Membrane Proteins; Mental Retardation, X-Linked; Mutation; Pedigree},
	Month = {Mar},
	Number = {3},
	Pages = {552-7},
	Pmc = {PMC1182268},
	Pmid = {14963808},
	Pst = {ppublish},
	Title = {X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family},
	Volume = {74},
	Year = {2004},
	Bdsk-Url-1 = {http://dx.doi.org/10.1086/382137}}

@article{Lai:2015aa,
	Abstract = {OBJECTIVE: The relationship between sex/gender differences and autism has attracted a variety of research ranging from clinical and neurobiological to etiological, stimulated by the male bias in autism prevalence. Findings are complex and do not always relate to each other in a straightforward manner. Distinct but interlinked questions on the relationship between sex/gender differences and autism remain underaddressed. To better understand the implications from existing research and to help design future studies, we propose a 4-level conceptual framework to clarify the embedded themes.
METHOD: We searched PubMed for publications before September 2014 using search terms "'sex OR gender OR females' AND autism." A total of 1,906 articles were screened for relevance, along with publications identified via additional literature reviews, resulting in 329 articles that were reviewed.
RESULTS: Level 1, "Nosological and diagnostic challenges," concerns the question, "How should autism be defined and diagnosed in males and females?" Level 2, "Sex/gender-independent and sex/gender-dependent characteristics," addresses the question, "What are the similarities and differences between males and females with autism?" Level 3, "General models of etiology: liability and threshold," asks the question, "How is the liability for developing autism linked to sex/gender?" Level 4, "Specific etiological-developmental mechanisms," focuses on the question, "What etiological-developmental mechanisms of autism are implicated by sex/gender and/or sexual/gender differentiation?"
CONCLUSIONS: Using this conceptual framework, findings can be more clearly summarized, and the implications of the links between findings from different levels can become clearer. Based on this 4-level framework, we suggest future research directions, methodology, and specific topics in sex/gender differences and autism.},
	Author = {Lai, Meng-Chuan and Lombardo, Michael V and Auyeung, Bonnie and Chakrabarti, Bhismadev and Baron-Cohen, Simon},
	Date-Added = {2016-07-09 20:01:05 +0000},
	Date-Modified = {2016-07-09 20:01:05 +0000},
	Doi = {10.1016/j.jaac.2014.10.003},
	Journal = {J Am Acad Child Adolesc Psychiatry},
	Journal-Full = {Journal of the American Academy of Child and Adolescent Psychiatry},
	Keywords = {autism; etiology; gender; nosology; sex},
	Month = {Jan},
	Number = {1},
	Pages = {11-24},
	Pmc = {PMC4284309},
	Pmid = {25524786},
	Pst = {ppublish},
	Title = {Sex/gender differences and autism: setting the scene for future research},
	Volume = {54},
	Year = {2015},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.jaac.2014.10.003}}

@article{Kong:2012aa,
	Abstract = {Mutations generate sequence diversity and provide a substrate for selection. The rate of de novo mutations is therefore of major importance to evolution. Here we conduct a study of genome-wide mutation rates by sequencing the entire genomes of 78 Icelandic parent-offspring trios at high coverage. We show that in our samples, with an average father's age of 29.7, the average de novo mutation rate is 1.20â€‰Ã—â€‰10(-8) per nucleotide per generation. Most notably, the diversity in mutation rate of single nucleotide polymorphisms is dominated by the age of the father at conception of the child. The effect is an increase of about two mutations per year. An exponential model estimates paternal mutations doubling every 16.5â€‰years. After accounting for random Poisson variation, father's age is estimated to explain nearly all of the remaining variation in the de novo mutation counts. These observations shed light on the importance of the father's age on the risk of diseases such as schizophrenia and autism.},
	Author = {Kong, Augustine and Frigge, Michael L and Masson, Gisli and Besenbacher, Soren and Sulem, Patrick and Magnusson, Gisli and Gudjonsson, Sigurjon A and Sigurdsson, Asgeir and Jonasdottir, Aslaug and Jonasdottir, Adalbjorg and Wong, Wendy S W and Sigurdsson, Gunnar and Walters, G Bragi and Steinberg, Stacy and Helgason, Hannes and Thorleifsson, Gudmar and Gudbjartsson, Daniel F and Helgason, Agnar and Magnusson, Olafur Th and Thorsteinsdottir, Unnur and Stefansson, Kari},
	Date-Added = {2016-07-09 20:00:57 +0000},
	Date-Modified = {2016-07-09 20:00:57 +0000},
	Doi = {10.1038/nature11396},
	Journal = {Nature},
	Journal-Full = {Nature},
	Mesh = {Adult; Autistic Disorder; Chromosomes, Human; Female; Genetic Predisposition to Disease; Genome, Human; Humans; Iceland; Male; Middle Aged; Mothers; Mutation Rate; Ovum; Paternal Age; Pedigree; Polymorphism, Single Nucleotide; Risk Factors; Schizophrenia; Selection, Genetic; Sequence Analysis, DNA; Spermatozoa; Young Adult},
	Month = {Aug},
	Number = {7412},
	Pages = {471-5},
	Pmc = {PMC3548427},
	Pmid = {22914163},
	Pst = {ppublish},
	Title = {Rate of de novo mutations and the importance of father's age to disease risk},
	Volume = {488},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature11396}}

@article{Klei:2012aa,
	Abstract = {UNLABELLED: 
BACKGROUND: Autism spectrum disorders (ASD) are early onset neurodevelopmental syndromes typified by impairments in reciprocal social interaction and communication, accompanied by restricted and repetitive behaviors. While rare and especially de novo genetic variation are known to affect liability, whether common genetic polymorphism plays a substantial role is an open question and the relative contribution of genes and environment is contentious. It is probable that the relative contributions of rare and common variation, as well as environment, differs between ASD families having only a single affected individual (simplex) versus multiplex families who have two or more affected individuals.
METHODS: By using quantitative genetics techniques and the contrast of ASD subjects to controls, we estimate what portion of liability can be explained by additive genetic effects, known as narrow-sense heritability. We evaluate relatives of ASD subjects using the same methods to evaluate the assumptions of the additive model and partition families by simplex/multiplex status to determine how heritability changes with status.
RESULTS: By analyzing common variation throughout the genome, we show that common genetic polymorphism exerts substantial additive genetic effects on ASD liability and that simplex/multiplex family status has an impact on the identified composition of that risk. As a fraction of the total variation in liability, the estimated narrow-sense heritability exceeds 60% for ASD individuals from multiplex families and is approximately 40% for simplex families. By analyzing parents, unaffected siblings and alleles not transmitted from parents to their affected children, we conclude that the data for simplex ASD families follow the expectation for additive models closely. The data from multiplex families deviate somewhat from an additive model, possibly due to parental assortative mating.
CONCLUSIONS: Our results, when viewed in the context of results from genome-wide association studies, demonstrate that a myriad of common variants of very small effect impacts ASD liability.},
	Author = {Klei, Lambertus and Sanders, Stephan J and Murtha, Michael T and Hus, Vanessa and Lowe, Jennifer K and Willsey, A Jeremy and Moreno-De-Luca, Daniel and Yu, Timothy W and Fombonne, Eric and Geschwind, Daniel and Grice, Dorothy E and Ledbetter, David H and Lord, Catherine and Mane, Shrikant M and Martin, Christa Lese and Martin, Donna M and Morrow, Eric M and Walsh, Christopher A and Melhem, Nadine M and Chaste, Pauline and Sutcliffe, James S and State, Matthew W and Cook, Jr, Edwin H and Roeder, Kathryn and Devlin, Bernie},
	Date-Added = {2016-07-09 20:00:50 +0000},
	Date-Modified = {2016-07-09 20:00:50 +0000},
	Doi = {10.1186/2040-2392-3-9},
	Journal = {Mol Autism},
	Journal-Full = {Molecular autism},
	Number = {1},
	Pages = {9},
	Pmc = {PMC3579743},
	Pmid = {23067556},
	Pst = {epublish},
	Title = {Common genetic variants, acting additively, are a major source of risk for autism},
	Volume = {3},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/2040-2392-3-9}}

@article{King:1975aa,
	Author = {King, M C and Wilson, A C},
	Date-Added = {2016-07-09 20:00:44 +0000},
	Date-Modified = {2016-07-09 20:00:44 +0000},
	Journal = {Science},
	Journal-Full = {Science (New York, N.Y.)},
	Mesh = {Alleles; Amino Acid Sequence; Animals; Biological Evolution; Electrophoresis; Enzymes; Genes; Genetic Code; Humans; Models, Biological; Mutation; Pan troglodytes; Protein Biosynthesis; Proteins},
	Month = {Apr},
	Number = {4184},
	Pages = {107-16},
	Pmid = {1090005},
	Pst = {ppublish},
	Title = {Evolution at two levels in humans and chimpanzees},
	Volume = {188},
	Year = {1975}}

@article{Kim:2011aa,
	Abstract = {OBJECTIVE: Experts disagree about the causes and significance of the recent increases in the prevalence of autism spectrum disorders (ASDs). Limited data on population base rates contribute to this uncertainty. Using a population-based sample, the authors sought to estimate the prevalence and describe the clinical characteristics of ASDs in school-age children.
METHOD: The target population was all 7- to 12-year-old children (N=55,266) in a South Korean community; the study used a high-probability group from special education schools and a disability registry and a low-probability, general-population sample from regular schools. To identify cases, the authors used the Autism Spectrum Screening Questionnaire for systematic, multi-informant screening. Parents of children who screened positive were offered comprehensive assessments using standardized diagnostic procedures.
RESULTS: The prevalence of ASDs was estimated to be 2.64% (95% CI=1.91-3.37), with 1.89% (95% CI=1.43-2.36) in the general-population sample and 0.75% (95% CI=0.58-0.93) in the high-probability group. ASD characteristics differed between the two groups: the male-to-female ratios were 2.5:1 and 5.1:1 in the general population sample and high-probability group, respectively, and the ratios of autistic disorders to other ASD subtypes were 1:2.6 and 2.6:1, respectively; 12% in the general-population sample had superior IQs, compared with 7% in the high-probability group; and 16% in the general-population sample had intellectual disability, compared with 59% in the high-probability group.
CONCLUSIONS: Two-thirds of ASD cases in the overall sample were in the mainstream school population, undiagnosed and untreated. These findings suggest that rigorous screening and comprehensive population coverage are necessary to produce more accurate ASD prevalence estimates and underscore the need for better detection, assessment, and services.},
	Author = {Kim, Young Shin and Leventhal, Bennett L and Koh, Yun-Joo and Fombonne, Eric and Laska, Eugene and Lim, Eun-Chung and Cheon, Keun-Ah and Kim, Soo-Jeong and Kim, Young-Key and Lee, Hyunkyung and Song, Dong-Ho and Grinker, Roy Richard},
	Date-Added = {2016-07-09 20:00:39 +0000},
	Date-Modified = {2016-07-09 20:00:39 +0000},
	Doi = {10.1176/appi.ajp.2011.10101532},
	Journal = {Am J Psychiatry},
	Journal-Full = {The American journal of psychiatry},
	Mesh = {Child; Child Development Disorders, Pervasive; Cross-Sectional Studies; Education, Special; Female; Health Surveys; Humans; Incidence; Intelligence; Mainstreaming (Education); Male; Republic of Korea; Sex Factors; Surveys and Questionnaires},
	Month = {Sep},
	Number = {9},
	Pages = {904-12},
	Pmid = {21558103},
	Pst = {ppublish},
	Title = {Prevalence of autism spectrum disorders in a total population sample},
	Volume = {168},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1176/appi.ajp.2011.10101532}}

@article{Jeste:2014aa,
	Abstract = {Autism spectrum disorder (ASD) represents a heterogeneous group of disorders, which presents a substantial challenge to diagnosis and treatment. Over the past decade, considerable progress has been made in the identification of genetic risk factors for ASD that define specific mechanisms and pathways underlying the associated behavioural deficits. In this Review, we discuss how some of the latest advances in the genetics of ASD have facilitated parsing of the phenotypic heterogeneity of this disorder. We argue that only through such advances will we begin to define endophenotypes that can benefit from targeted, hypothesis-driven treatments. We review the latest technologies used to identify and characterize the genetics underlying ASD and then consider three themes-single-gene disorders, the gender bias in ASD, and the genetics of neurological comorbidities-that highlight ways in which we can use genetics to define the many phenotypes within the autism spectrum. We also present current clinical guidelines for genetic testing in ASD and their implications for prognosis and treatment.},
	Author = {Jeste, Shafali S and Geschwind, Daniel H},
	Date-Added = {2016-07-09 20:00:32 +0000},
	Date-Modified = {2016-07-09 20:00:32 +0000},
	Doi = {10.1038/nrneurol.2013.278},
	Journal = {Nat Rev Neurol},
	Journal-Full = {Nature reviews. Neurology},
	Mesh = {Animals; Brain; Child Development Disorders, Pervasive; Genetic Predisposition to Disease; Genetic Testing; Humans; Methyl-CpG-Binding Protein 2; Mutation},
	Month = {Feb},
	Number = {2},
	Pages = {74-81},
	Pmc = {PMC4125617},
	Pmid = {24468882},
	Pst = {ppublish},
	Title = {Disentangling the heterogeneity of autism spectrum disorder through genetic findings},
	Volume = {10},
	Year = {2014},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nrneurol.2013.278}}

@article{Jacquemont:2014aa,
	Abstract = {Increased male prevalence has been repeatedly reported in several neurodevelopmental disorders (NDs), leading to the concept of a "female protective model." We investigated the molecular basis of this sex-based difference in liability and demonstrated an excess of deleterious autosomal copy-number variants (CNVs) in females compared to males (odds ratio [OR] = 1.46, p = 8 Ã— 10(-10)) in a cohort of 15,585 probands ascertained for NDs. In an independent autism spectrum disorder (ASD) cohort of 762 families, we found a 3-fold increase in deleterious autosomal CNVs (p = 7 Ã— 10(-4)) and an excess of private deleterious single-nucleotide variants (SNVs) in female compared to male probands (OR = 1.34, p = 0.03). We also showed that the deleteriousness of autosomal SNVs was significantly higher in female probands (p = 0.0006). A similar bias was observed in parents of probands ascertained for NDs. Deleterious CNVs (>400 kb) were maternally inherited more often (up to 64%, p = 10(-15)) than small CNVs < 400 kb (OR = 1.45, p = 0.0003). In the ASD cohort, increased maternal transmission was also observed for deleterious CNVs and SNVs. Although ASD females showed higher mutational burden and lower cognition, the excess mutational burden remained, even after adjustment for those cognitive differences. These results strongly suggest that females have an increased etiological burden unlinked to rare deleterious variants on the X chromosome. Carefully phenotyped and genotyped cohorts will be required for identifying the symptoms, which show gender-specific liability to mutational burden.},
	Author = {Jacquemont, S{\'e}bastien and Coe, Bradley P and Hersch, Micha and Duyzend, Michael H and Krumm, Niklas and Bergmann, Sven and Beckmann, Jacques S and Rosenfeld, Jill A and Eichler, Evan E},
	Date-Added = {2016-07-09 20:00:20 +0000},
	Date-Modified = {2016-07-09 20:00:20 +0000},
	Doi = {10.1016/j.ajhg.2014.02.001},
	Journal = {Am J Hum Genet},
	Journal-Full = {American journal of human genetics},
	Mesh = {Adolescent; Adult; Aged; Child Development Disorders, Pervasive; Chromosomes, Artificial, Bacterial; Cognition Disorders; Cohort Studies; DNA Copy Number Variations; DNA Mutational Analysis; Databases, Genetic; Developmental Disabilities; Female; Gene Deletion; Genotype; Humans; Male; Markov Chains; Middle Aged; Mutation; Odds Ratio; Oligonucleotide Array Sequence Analysis; Phenotype; Polymorphism, Single Nucleotide; Sex Factors; Young Adult},
	Month = {Mar},
	Number = {3},
	Pages = {415-25},
	Pmc = {PMC3951938},
	Pmid = {24581740},
	Pst = {ppublish},
	Title = {A higher mutational burden in females supports a "female protective model" in neurodevelopmental disorders},
	Volume = {94},
	Year = {2014},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.ajhg.2014.02.001}}

@article{Ishikawa-Brush:1997aa,
	Abstract = {An X;8 translocation was identified in a 27-year-old female patient manifesting multiple exostoses and autism accompanied by mental retardation and epilepsy. Through molecular analysis using yeast artificial chromosomes (YACs) and cosmid clones, the translocation breakpoint was isolated and confirmed to be reciprocal within a 5'-GGCA-3' sequence found on both X and 8 chromosomes without gain or loss of a single nucleotide. The translocation breakpoint on the X chromosome occurred in the first intron of the gastrin-releasing peptide receptor (GRPR) gene and that on chromosome 8 occurred approximately 30 kb distal to the 3' end of the Syndecan-2 gene (SDC2), also known as human heparan sulfate proteoglycan or fibroglycan. The GRPR gene was shown to escape X-inactivation. A dosage effect of the GRPR and a position effect of the SDC2 gene may, however, contribute the phenotype observed in this patient since the orientation of these genes with respect to the translocation was incompatible with the formation of a fusion gene. Investigation of mutations in these two genes in unrelated patients with either autism or multiple exostoses as well as linkage and association studies is needed to validate them as candidate genes.},
	Author = {Ishikawa-Brush, Y and Powell, J F and Bolton, P and Miller, A P and Francis, F and Willard, H F and Lehrach, H and Monaco, A P},
	Date-Added = {2016-07-09 20:00:14 +0000},
	Date-Modified = {2016-07-09 20:00:14 +0000},
	Journal = {Hum Mol Genet},
	Journal-Full = {Human molecular genetics},
	Mesh = {Adult; Autistic Disorder; Base Sequence; Chromosomes, Artificial, Yeast; Chromosomes, Human, Pair 8; Cloning, Molecular; Cosmids; DNA; Exons; Exostoses, Multiple Hereditary; Female; Gene Expression; Humans; Membrane Glycoproteins; Molecular Sequence Data; Proteoglycans; Receptors, Bombesin; Restriction Mapping; Syndecan-2; Translocation, Genetic; X Chromosome},
	Month = {Aug},
	Number = {8},
	Pages = {1241-50},
	Pmid = {9259269},
	Pst = {ppublish},
	Title = {Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3' to the SDC2 gene},
	Volume = {6},
	Year = {1997}}

@article{Iossifov:2012aa,
	Abstract = {Exome sequencing of 343 families, each with a single child on the autism spectrum and at least one unaffected sibling, reveal de novo small indels and point substitutions, which come mostly from the paternal line in an age-dependent manner. We do not see significantly greater numbers of de novo missense mutations in affected versus unaffected children, but gene-disrupting mutations (nonsense, splice site, and frame shifts) are twice as frequent, 59 to 28. Based on this differential and the number of recurrent and total targets of gene disruption found in our and similar studies, we estimate between 350 and 400 autism susceptibility genes. Many of the disrupted genes in these studies are associated with the fragile X protein, FMRP, reinforcing links between autism and synaptic plasticity. We find FMRP-associated genes are under greater purifying selection than the remainder of genes and suggest they are especially dosage-sensitive targets of cognitive disorders.},
	Author = {Iossifov, Ivan and Ronemus, Michael and Levy, Dan and Wang, Zihua and Hakker, Inessa and Rosenbaum, Julie and Yamrom, Boris and Lee, Yoon-Ha and Narzisi, Giuseppe and Leotta, Anthony and Kendall, Jude and Grabowska, Ewa and Ma, Beicong and Marks, Steven and Rodgers, Linda and Stepansky, Asya and Troge, Jennifer and Andrews, Peter and Bekritsky, Mitchell and Pradhan, Kith and Ghiban, Elena and Kramer, Melissa and Parla, Jennifer and Demeter, Ryan and Fulton, Lucinda L and Fulton, Robert S and Magrini, Vincent J and Ye, Kenny and Darnell, Jennifer C and Darnell, Robert B and Mardis, Elaine R and Wilson, Richard K and Schatz, Michael C and McCombie, W Richard and Wigler, Michael},
	Date-Added = {2016-07-09 20:00:06 +0000},
	Date-Modified = {2016-07-09 20:00:06 +0000},
	Doi = {10.1016/j.neuron.2012.04.009},
	Journal = {Neuron},
	Journal-Full = {Neuron},
	Mesh = {Child; Child Development Disorders, Pervasive; Child, Preschool; Family Health; Female; Fragile X Mental Retardation Protein; Gene Dosage; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Models, Molecular; Mutation; Parents; Phenotype},
	Month = {Apr},
	Number = {2},
	Pages = {285-99},
	Pmc = {PMC3619976},
	Pmid = {22542183},
	Pst = {ppublish},
	Title = {De novo gene disruptions in children on the autistic spectrum},
	Volume = {74},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.neuron.2012.04.009}}

@article{Iossifov:2014aa,
	Abstract = {Whole exome sequencing has proven to be a powerful tool for understanding the genetic architecture of human disease. Here we apply it to more than 2,500 simplex families, each having a child with an autistic spectrum disorder. By comparing affected to unaffected siblings, we show that 13% of de novo missense mutations and 43% of de novo likely gene-disrupting (LGD) mutations contribute to 12% and 9% of diagnoses, respectively. Including copy number variants, coding de novo mutations contribute to about 30% of all simplex and 45% of female diagnoses. Almost all LGD mutations occur opposite wild-type alleles. LGD targets in affected females significantly overlap the targets in males of lower intelligence quotient (IQ), but neither overlaps significantly with targets in males of higher IQ. We estimate that LGD mutation in about 400 genes can contribute to the joint class of affected females and males of lower IQ, with an overlapping and similar number of genes vulnerable to contributory missense mutation. LGD targets in the joint class overlap with published targets for intellectual disability and schizophrenia, and are enriched for chromatin modifiers, FMRP-associated genes and embryonically expressed genes. Most of the significance for the latter comes from affected females.},
	Author = {Iossifov, Ivan and O'Roak, Brian J and Sanders, Stephan J and Ronemus, Michael and Krumm, Niklas and Levy, Dan and Stessman, Holly A and Witherspoon, Kali T and Vives, Laura and Patterson, Karynne E and Smith, Joshua D and Paeper, Bryan and Nickerson, Deborah A and Dea, Jeanselle and Dong, Shan and Gonzalez, Luis E and Mandell, Jeffrey D and Mane, Shrikant M and Murtha, Michael T and Sullivan, Catherine A and Walker, Michael F and Waqar, Zainulabedin and Wei, Liping and Willsey, A Jeremy and Yamrom, Boris and Lee, Yoon-ha and Grabowska, Ewa and Dalkic, Ertugrul and Wang, Zihua and Marks, Steven and Andrews, Peter and Leotta, Anthony and Kendall, Jude and Hakker, Inessa and Rosenbaum, Julie and Ma, Beicong and Rodgers, Linda and Troge, Jennifer and Narzisi, Giuseppe and Yoon, Seungtai and Schatz, Michael C and Ye, Kenny and McCombie, W Richard and Shendure, Jay and Eichler, Evan E and State, Matthew W and Wigler, Michael},
	Date-Added = {2016-07-09 19:59:58 +0000},
	Date-Modified = {2016-07-09 19:59:58 +0000},
	Doi = {10.1038/nature13908},
	Journal = {Nature},
	Journal-Full = {Nature},
	Mesh = {Child; Child Development Disorders, Pervasive; Cluster Analysis; Exome; Female; Genes; Genetic Predisposition to Disease; Humans; Intelligence Tests; Male; Mutation; Open Reading Frames; Reproducibility of Results},
	Month = {Nov},
	Number = {7526},
	Pages = {216-21},
	Pmc = {PMC4313871},
	Pmid = {25363768},
	Pst = {ppublish},
	Title = {The contribution of de novo coding mutations to autism spectrum disorder},
	Volume = {515},
	Year = {2014},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature13908}}

@article{Developmental-Disabilities-Monitoring-Network-Surveillance-Year-2010-Principal-Investigators:2014aa,
	Abstract = {PROBLEM/CONDITION: Autism spectrum disorder (ASD).
PERIOD COVERED: 2010.
DESCRIPTION OF SYSTEM: The Autism and Developmental Disabilities Monitoring (ADDM) Network is an active surveillance system in the United States that provides estimates of the prevalence of ASD and other characteristics among children aged 8 years whose parents or guardians live in 11 ADDM sites in the United States. ADDM surveillance is conducted in two phases. The first phase consists of screening and abstracting comprehensive evaluations performed by professional providers in the community. Multiple data sources for these evaluations include general pediatric health clinics and specialized programs for children with developmental disabilities. In addition, most ADDM Network sites also review and abstract records of children receiving special education services in public schools. The second phase involves review of all abstracted evaluations by trained clinicians to determine ASD surveillance case status. A child meets the surveillance case definition for ASD if a comprehensive evaluation of that child completed by a qualified professional describes behaviors consistent with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) diagnostic criteria for any of the following conditions: autistic disorder, pervasive developmental disorder-not otherwise specified (including atypical autism), or Asperger disorder. This report provides updated prevalence estimates for ASD from the 2010 surveillance year. In addition to prevalence estimates, characteristics of the population of children with ASD are described.
RESULTS: For 2010, the overall prevalence of ASD among the ADDM sites was 14.7 per 1,000 (one in 68) children aged 8 years. Overall ASD prevalence estimates varied among sites from 5.7 to 21.9 per 1,000 children aged 8 years. ASD prevalence estimates also varied by sex and racial/ethnic group. Approximately one in 42 boys and one in 189 girls living in the ADDM Network communities were identified as having ASD. Non-Hispanic white children were approximately 30% more likely to be identified with ASD than non-Hispanic black children and were almost 50% more likely to be identified with ASD than Hispanic children. Among the seven sites with sufficient data on intellectual ability, 31% of children with ASD were classified as having IQ scores in the range of intellectual disability (IQ â‰¤70), 23% in the borderline range (IQ = 71-85), and 46% in the average or above average range of intellectual ability (IQ >85). The proportion of children classified in the range of intellectual disability differed by race/ethnicity. Approximately 48% of non-Hispanic black children with ASD were classified in the range of intellectual disability compared with 38% of Hispanic children and 25% of non-Hispanic white children. The median age of earliest known ASD diagnosis was 53 months and did not differ significantly by sex or race/ethnicity.
INTERPRETATION: These findings from CDC's ADDM Network, which are based on 2010 data reported from 11 sites, provide updated population-based estimates of the prevalence of ASD in multiple communities in the United States. Because the ADDM Network sites do not provide a representative sample of the entire United States, the combined prevalence estimates presented in this report cannot be generalized to all children aged 8 years in the United States population. Consistent with previous reports from the ADDM Network, findings from the 2010 surveillance year were marked by significant variations in ASD prevalence by geographic area, sex, race/ethnicity, and level of intellectual ability. The extent to which this variation might be attributable to diagnostic practices, underrecognition of ASD symptoms in some racial/ethnic groups, socioeconomic disparities in access to services, and regional differences in clinical or school-based practices that might influence the findings in this report is unclear.
PUBLIC HEALTH ACTION: ADDM Network investigators will continue to monitor the prevalence of ASD in select communities, with a focus on exploring changes within these communities that might affect both the observed prevalence of ASD and population-based characteristics of children identified with ASD. Although ASD is sometimes diagnosed by 2 years of age, the median age of the first ASD diagnosis remains older than age 4 years in the ADDM Network communities. Recommendations from the ADDM Network include enhancing strategies to address the need for 1) standardized, widely adopted measures to document ASD severity and functional limitations associated with ASD diagnosis; 2) improved recognition and documentation of symptoms of ASD, particularly among both boys and girls, children without intellectual disability, and children in all racial/ethnic groups; and 3) decreasing the age when children receive their first evaluation for and a diagnosis of ASD and are enrolled in community-based support systems.},
	Author = {{Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators} and {Centers for Disease Control and Prevention (CDC)}},
	Date-Added = {2016-07-09 19:59:52 +0000},
	Date-Modified = {2016-07-09 19:59:52 +0000},
	Journal = {MMWR Surveill Summ},
	Journal-Full = {Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002)},
	Mesh = {Child; Child Development Disorders, Pervasive; Ethnic Groups; Female; Humans; Male; Population Surveillance; Prevalence; Sex Distribution; United States},
	Month = {Mar},
	Number = {2},
	Pages = {1-21},
	Pmid = {24670961},
	Pst = {ppublish},
	Title = {Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010},
	Volume = {63},
	Year = {2014}}

@article{Idring:2012aa,
	Abstract = {OBJECTIVE: Reports of rising prevalence of autism spectrum disorders (ASD), along with their profound personal and societal burden, emphasize the need of methodologically sound studies to explore their causes and consequences. We here present the design of a large intergenerational resource for ASD research, along with population-based prevalence estimates of ASD and their diagnostic validity.
METHOD: The Stockholm Youth Cohort is a record-linkage study comprising all individuals aged 0-17 years, ever resident in Stockholm County in 2001-2007 (Nâ€Š=â€Š589,114). ASD cases (Nâ€Š=â€Š5,100) were identified using a multisource approach, involving registers covering all pathways to ASD diagnosis and care, and categorized according to co-morbid intellectual disability. Prospectively recorded information on potential determinants and consequences of ASD were retrieved from national and regional health and administrative registers. Case ascertainment was validated through case-note review, and cross validation with co-existing cases in a national twin study.
RESULTS: The 2007 year prevalence of ASD in all children and young people was 11.5 per 1,000 (95% confidence interval 11.2-11.8), with a co-morbid intellectual disability recorded in 42.6% (41.0-44.2) of cases. We found 96.0% (92.0-98.4) of reviewed case-notes being consistent with a diagnosis of ASD, and confirmed ASD in 85.2% (66.2-95.8) of affected twins.
CONCLUSIONS: Findings from this contemporary study accords with recently reported prevalence estimates from Western countries at around 1%, based on valid case ascertainment. The Stockholm Youth Cohort, in light of the availability of extensive information from Sweden's registers, constitutes an important resource for ASD research. On-going work, including collection of biological samples, will enrich the study further.},
	Author = {Idring, Selma and Rai, Dheeraj and Dal, Henrik and Dalman, Christina and Sturm, Harald and Zander, Eric and Lee, Brian K and Serlachius, Eva and Magnusson, Cecilia},
	Date-Added = {2016-07-09 19:59:46 +0000},
	Date-Modified = {2016-07-09 19:59:46 +0000},
	Doi = {10.1371/journal.pone.0041280},
	Journal = {PLoS One},
	Journal-Full = {PloS one},
	Mesh = {Adolescent; Child; Child Development Disorders, Pervasive; Child, Preschool; Cohort Studies; Female; Humans; Intellectual Disability; Male; Prevalence; Reproducibility of Results; Sweden; Young Adult},
	Number = {7},
	Pages = {e41280},
	Pmc = {PMC3401114},
	Pmid = {22911770},
	Pst = {ppublish},
	Title = {Autism spectrum disorders in the Stockholm Youth Cohort: design, prevalence and validity},
	Volume = {7},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pone.0041280}}

@article{Hoffman:2016aa,
	Abstract = {Autism spectrum disorders (ASDs) are a group of devastating neurodevelopmental syndromes that affect up to 1 in 68 children. Despite advances in the identification of ASD risk genes, the mechanisms underlying ASDs remain unknown. Homozygous loss-of-function mutations in Contactin Associated Protein-like 2 (CNTNAP2) are strongly linked to ASDs. Here we investigate the function of Cntnap2 and undertake pharmacological screens to identify phenotypic suppressors. We find that zebrafish cntnap2 mutants display GABAergic deficits, particularly in the forebrain, and sensitivity to drug-induced seizures. High-throughput behavioral profiling identifies nighttime hyperactivity in cntnap2 mutants, while pharmacological testing reveals dysregulation of GABAergic and glutamatergic systems. Finally, we find that estrogen receptor agonists elicit a behavioral fingerprint anti-correlative to that of cntnap2 mutants and show that the phytoestrogen biochanin A specifically reverses the mutant behavioral phenotype. These results identify estrogenic compounds as phenotypic suppressors and illuminate novel pharmacological pathways with relevance to autism.},
	Author = {Hoffman, Ellen J and Turner, Katherine J and Fernandez, Joseph M and Cifuentes, Daniel and Ghosh, Marcus and Ijaz, Sundas and Jain, Roshan A and Kubo, Fumi and Bill, Brent R and Baier, Herwig and Granato, Michael and Barresi, Michael J F and Wilson, Stephen W and Rihel, Jason and State, Matthew W and Giraldez, Antonio J},
	Date-Added = {2016-07-09 19:59:39 +0000},
	Date-Modified = {2016-07-09 19:59:39 +0000},
	Doi = {10.1016/j.neuron.2015.12.039},
	Journal = {Neuron},
	Journal-Full = {Neuron},
	Mesh = {Animals; Animals, Genetically Modified; Autistic Disorder; Disease Models, Animal; Estrogens; Gene Expression Regulation; Genistein; Green Fluorescent Proteins; Humans; Larva; Luminescent Proteins; Membrane Proteins; Motor Activity; Mutation; Nerve Tissue Proteins; Phenotype; Phytoestrogens; Psychotropic Drugs; Seizures; Sleep-Wake Transition Disorders; Vesicular Glutamate Transport Protein 2; Zebrafish},
	Month = {Feb},
	Number = {4},
	Pages = {725-33},
	Pmc = {PMC4766582},
	Pmid = {26833134},
	Pst = {ppublish},
	Title = {Estrogens Suppress a Behavioral Phenotype in Zebrafish Mutants of the Autism Risk Gene, CNTNAP2},
	Volume = {89},
	Year = {2016},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.neuron.2015.12.039}}

@article{Halladay:2015aa,
	Abstract = {One of the most consistent findings in autism spectrum disorder (ASD) research is a higher rate of ASD diagnosis in males than females. Despite this, remarkably little research has focused on the reasons for this disparity. Better understanding of this sex difference could lead to major advancements in the prevention or treatment of ASD in both males and females. In October of 2014, Autism Speaks and the Autism Science Foundation co-organized a meeting that brought together almost 60 clinicians, researchers, parents, and self-identified autistic individuals. Discussion at the meeting is summarized here with recommendations on directions of future research endeavors.},
	Author = {Halladay, Alycia K and Bishop, Somer and Constantino, John N and Daniels, Amy M and Koenig, Katheen and Palmer, Kate and Messinger, Daniel and Pelphrey, Kevin and Sanders, Stephan J and Singer, Alison Tepper and Taylor, Julie Lounds and Szatmari, Peter},
	Date-Added = {2016-07-09 19:59:32 +0000},
	Date-Modified = {2016-07-09 19:59:32 +0000},
	Doi = {10.1186/s13229-015-0019-y},
	Journal = {Mol Autism},
	Journal-Full = {Molecular autism},
	Keywords = {Autism; Diagnosis; Female; Protection; Research; Symposium},
	Pages = {36},
	Pmc = {PMC4465158},
	Pmid = {26075049},
	Pst = {epublish},
	Title = {Sex and gender differences in autism spectrum disorder: summarizing evidence gaps and identifying emerging areas of priority},
	Volume = {6},
	Year = {2015},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/s13229-015-0019-y}}

@article{Gronborg:2013aa,
	Abstract = {IMPORTANCE: To date, this is the first population-based study to examine the recurrence risk for autism spectrum disorders (ASDs), including time trends, and the first study to consider the ASDs recurrence risk for full- and half-siblings.
OBJECTIVES: To estimate the relative recurrence risk for ASDs in a Danish population, including recurrence in full- and half-siblings, and to examine time trends in ASDs relative to the recurrence risk.
DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study in Denmark. All children (about 1.5 million) born in Denmark between January 1, 1980, and December 31, 2004, were identified and followed up to December 31, 2010. We identified a maternal sibling subcohort derived from mothers with at least 2 children and a paternal sibling subcohort derived from fathers with at least 2 children.
EXPOSURES: Children having an older sibling with ASDs are compared with children not having an older sibling with ASDs.
MAIN OUTCOMES AND MEASURES: The adjusted hazard ratio for ASDs among children having an older sibling with ASDs compared with children not having an older sibling with ASDs. RESULTS The overall relative recurrence risk for ASDs was 6.9 (95% CI, 6.1-7.8), and it did not change significantly over time; similar risks were observed in maternal and paternal full-siblings. The relative recurrence risks were 2.4 (95% CI, 1.4-4.1) for maternal half-siblings and 1.5 (95% CI, 0.7-3.4) for paternal half-siblings.
CONCLUSIONS AND RELEVANCE: Our population-based recurrence risk estimate is lower than the recently reported estimates from clinical samples. Our results demonstrate no time trend in the ASDs recurrence risk as seen in the ASDs prevalence. The difference in the recurrence risk between full- and half-siblings supports the role of genetics in ASDs, while the significant recurrence risk in maternal half-siblings may support the role of factors associated with pregnancy and the maternal intrauterine environment in ASDs.},
	Author = {Gr{\o}nborg, Therese K and Schendel, Diana E and Parner, Erik T},
	Date-Added = {2016-07-09 19:59:21 +0000},
	Date-Modified = {2016-07-09 19:59:21 +0000},
	Doi = {10.1001/jamapediatrics.2013.2259},
	Journal = {JAMA Pediatr},
	Journal-Full = {JAMA pediatrics},
	Mesh = {Child; Child Development Disorders, Pervasive; Cohort Studies; Denmark; Female; Humans; Male; Prevalence; Proportional Hazards Models; Recurrence; Registries; Risk; Siblings},
	Month = {Oct},
	Number = {10},
	Pages = {947-53},
	Pmc = {PMC4610344},
	Pmid = {23959427},
	Pst = {ppublish},
	Title = {Recurrence of autism spectrum disorders in full- and half-siblings and trends over time: a population-based cohort study},
	Volume = {167},
	Year = {2013},
	Bdsk-Url-1 = {http://dx.doi.org/10.1001/jamapediatrics.2013.2259}}

@article{Geschwind:2001aa,
	Author = {Geschwind, D H and Sowinski, J and Lord, C and Iversen, P and Shestack, J and Jones, P and Ducat, L and Spence, S J and {AGRE Steering Committee}},
	Date-Added = {2016-07-09 19:58:48 +0000},
	Date-Modified = {2016-07-09 19:58:48 +0000},
	Doi = {10.1086/321292},
	Journal = {Am J Hum Genet},
	Journal-Full = {American journal of human genetics},
	Mesh = {Autistic Disorder; Databases as Topic; Female; Humans; Internet; Male; Patient Selection; Pedigree; Sample Size},
	Month = {Aug},
	Number = {2},
	Pages = {463-6},
	Pmc = {PMC1235320},
	Pmid = {11452364},
	Pst = {ppublish},
	Title = {The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions},
	Volume = {69},
	Year = {2001},
	Bdsk-Url-1 = {http://dx.doi.org/10.1086/321292}}

@article{Gaugler:2014aa,
	Abstract = {A key component of genetic architecture is the allelic spectrum influencing trait variability. For autism spectrum disorder (herein termed autism), the nature of the allelic spectrum is uncertain. Individual risk-associated genes have been identified from rare variation, especially de novo mutations. From this evidence, one might conclude that rare variation dominates the allelic spectrum in autism, yet recent studies show that common variation, individually of small effect, has substantial impact en masse. At issue is how much of an impact relative to rare variation this common variation has. Using a unique epidemiological sample from Sweden, new methods that distinguish total narrow-sense heritability from that due to common variation and synthesis of results from other studies, we reach several conclusions about autism's genetic architecture: its narrow-sense heritability is âˆ¼52.4%, with most due to common variation, and rare de novo mutations contribute substantially to individual liability, yet their contribution to variance in liability, 2.6%, is modest compared to that for heritable variation.},
	Author = {Gaugler, Trent and Klei, Lambertus and Sanders, Stephan J and Bodea, Corneliu A and Goldberg, Arthur P and Lee, Ann B and Mahajan, Milind and Manaa, Dina and Pawitan, Yudi and Reichert, Jennifer and Ripke, Stephan and Sandin, Sven and Sklar, Pamela and Svantesson, Oscar and Reichenberg, Abraham and Hultman, Christina M and Devlin, Bernie and Roeder, Kathryn and Buxbaum, Joseph D},
	Date-Added = {2016-07-09 19:58:39 +0000},
	Date-Modified = {2016-07-09 19:58:39 +0000},
	Doi = {10.1038/ng.3039},
	Journal = {Nat Genet},
	Journal-Full = {Nature genetics},
	Mesh = {Adolescent; Adult; Aged; Alleles; Autistic Disorder; Child; Genetic Predisposition to Disease; Humans; Middle Aged; Mutation; Polymorphism, Single Nucleotide; Risk Factors; Sweden; Young Adult},
	Month = {Aug},
	Number = {8},
	Pages = {881-5},
	Pmc = {PMC4137411},
	Pmid = {25038753},
	Pst = {ppublish},
	Title = {Most genetic risk for autism resides with common variation},
	Volume = {46},
	Year = {2014},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/ng.3039}}

@article{Frazier:2014aa,
	Abstract = {OBJECTIVE: To examine differences in behavioral symptoms and cognitive functioning between males and females with autism spectrum disorder (ASD).
METHOD: We analyzed data from 2,418 probands with autism (304 females and 2,114 males) included in the Simons Simplex Collection. Sex differences were evaluated across measures of autism symptoms, cognitive and motor functioning, adaptive behavior, and associated behavior problems. Measurement bias was examined using latent variable models of symptoms. Unadjusted and propensity-adjusted analyses were computed to ensure that sex differences were not due to unbalanced sampling. Moderator and mediator analyses evaluated whether sex differences were modified by clinical characteristics or were driven by cognitive ability.
RESULTS: Females with ASD had greater social communication impairment, lower levels of restricted interests, lower cognitive ability, weaker adaptive skills, and greater externalizing problems relative to males. Symptom differences could not be accounted for by measurement differences, indicating that diagnostic instruments captured autism similarly in males and females. IQ reductions mediated greater social impairment and reduced adaptive behavior in females with ASD, but did not mediate reductions in restricted interests or increases in irritability.
CONCLUSIONS: A specific female ASD phenotype is emerging that cannot be accounted for by differential symptom measurement. The present data suggest that the relatively low proportion of high-functioning females may reflect the effect of protective biological factors or may be due to under-identification. Additional carefully accrued samples are needed to confirm the present pattern and to evaluate whether observed sex ratios in high-functioning cases are reduced if female-specific indicators of restricted interests are included.},
	Author = {Frazier, Thomas W and Georgiades, Stelios and Bishop, Somer L and Hardan, Antonio Y},
	Date-Added = {2016-07-09 19:58:32 +0000},
	Date-Modified = {2016-07-09 19:58:32 +0000},
	Doi = {10.1016/j.jaac.2013.12.004},
	Journal = {J Am Acad Child Adolesc Psychiatry},
	Journal-Full = {Journal of the American Academy of Child and Adolescent Psychiatry},
	Keywords = {autism spectrum disorder (ASD); behavior problems; cognitive; females; restricted interests},
	Mesh = {Adolescent; Behavioral Symptoms; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognition Disorders; Female; Humans; Male; Registries; Sex Factors; Social Behavior},
	Month = {Mar},
	Number = {3},
	Pages = {329-40.e1-3},
	Pmc = {PMC3935179},
	Pmid = {24565360},
	Pst = {ppublish},
	Title = {Behavioral and cognitive characteristics of females and males with autism in the Simons Simplex Collection},
	Volume = {53},
	Year = {2014},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.jaac.2013.12.004}}

@article{Fombonne:2009aa,
	Abstract = {This article reviews the results of 43 studies published since 1966 that provided estimates for the prevalence of pervasive developmental disorders (PDDs), including autistic disorder, Asperger disorder, PDD not otherwise specified, and childhood disintegrative disorder. The prevalence of autistic disorder has increased in recent surveys and current estimates of prevalence are around 20/10,000, whereas the prevalence for PDD not otherwise specified is around 30/10,000 in recent surveys. Prevalence of Asperger disorder is much lower than that for autistic disorder and childhood disintegrative disorder is a very rare disorder with a prevalence of about 2/100,000. Combined all together, recent studies that have examined the whole spectrum of PDDs have consistently provided estimates in the 60-70/10,000 range, making PDD one of the most frequent childhood neurodevelopmental disorders. The meaning of the increase in prevalence in recent decades is reviewed. There is evidence that the broadening of the concept, the expansion of diagnostic criteria, the development of services, and improved awareness of the condition have played a major role in explaining this increase, although it cannot be ruled out that other factors might have also contributed to that trend.},
	Author = {Fombonne, Eric},
	Date-Added = {2016-07-09 19:58:24 +0000},
	Date-Modified = {2016-07-09 19:58:24 +0000},
	Doi = {10.1203/PDR.0b013e31819e7203},
	Journal = {Pediatr Res},
	Journal-Full = {Pediatric research},
	Mesh = {Autistic Disorder; Child; Child Development Disorders, Pervasive; Health Surveys; Humans; Research Design},
	Month = {Jun},
	Number = {6},
	Pages = {591-8},
	Pmid = {19218885},
	Pst = {ppublish},
	Title = {Epidemiology of pervasive developmental disorders},
	Volume = {65},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1203/PDR.0b013e31819e7203}}

@article{Fischbach:2010aa,
	Abstract = {In an effort to identify de novo genetic variants that contribute to the overall risk of autism, the Simons Foundation Autism Research Initiative (SFARI) has gathered a unique sample called the Simons Simplex Collection (SSC). More than 2000 families have been evaluated to date. On average, probands in the current sample exhibit moderate to severe autistic symptoms with relatively little intellectual disability. An interactive database has been created to facilitate correlations between clinical, genetic, and neurobiological data.},
	Author = {Fischbach, Gerald D and Lord, Catherine},
	Date-Added = {2016-07-09 19:58:14 +0000},
	Date-Modified = {2016-07-09 19:58:14 +0000},
	Doi = {10.1016/j.neuron.2010.10.006},
	Journal = {Neuron},
	Journal-Full = {Neuron},
	Mesh = {Autistic Disorder; Data Collection; Family Health; Female; Humans; Information Dissemination; Male; Phenotype; Reproducibility of Results; Risk Factors},
	Month = {Oct},
	Number = {2},
	Pages = {192-5},
	Pmid = {20955926},
	Pst = {ppublish},
	Title = {The Simons Simplex Collection: a resource for identification of autism genetic risk factors},
	Volume = {68},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.neuron.2010.10.006}}

@article{Emison:2005aa,
	Abstract = {The identification of common variants that contribute to the genesis of human inherited disorders remains a significant challenge. Hirschsprung disease (HSCR) is a multifactorial, non-mendelian disorder in which rare high-penetrance coding sequence mutations in the receptor tyrosine kinase RET contribute to risk in combination with mutations at other genes. We have used family-based association studies to identify a disease interval, and integrated this with comparative and functional genomic analysis to prioritize conserved and functional elements within which mutations can be sought. We now show that a common non-coding RET variant within a conserved enhancer-like sequence in intron 1 is significantly associated with HSCR susceptibility and makes a 20-fold greater contribution to risk than rare alleles do. This mutation reduces in vitro enhancer activity markedly, has low penetrance, has different genetic effects in males and females, and explains several features of the complex inheritance pattern of HSCR. Thus, common low-penetrance variants, identified by association studies, can underlie both common and rare diseases.},
	Author = {Emison, Eileen Sproat and McCallion, Andrew S and Kashuk, Carl S and Bush, Richard T and Grice, Elizabeth and Lin, Shin and Portnoy, Matthew E and Cutler, David J and Green, Eric D and Chakravarti, Aravinda},
	Date-Added = {2016-07-09 19:58:06 +0000},
	Date-Modified = {2016-07-09 19:58:06 +0000},
	Doi = {10.1038/nature03467},
	Journal = {Nature},
	Journal-Full = {Nature},
	Mesh = {Animals; Enhancer Elements, Genetic; Female; Gene Frequency; Genetic Predisposition to Disease; Genomics; Haplotypes; Hirschsprung Disease; Humans; Linkage Disequilibrium; Male; Mice; Molecular Sequence Data; Mutation; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Sex Characteristics},
	Month = {Apr},
	Number = {7035},
	Pages = {857-63},
	Pmid = {15829955},
	Pst = {ppublish},
	Title = {A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk},
	Volume = {434},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature03467}}

@article{Dong:2014aa,
	Abstract = {Whole-exome sequencing (WES) studies have demonstrated the contribution of de novo loss-of-function single-nucleotide variants (SNVs) to autism spectrum disorder (ASD). However, challenges in the reliable detection of de novo insertions and deletions (indels) have limited inclusion of these variants in prior analyses. By applying a robust indel detection method to WES data from 787 ASD families (2,963 individuals), we demonstrate that de novo frameshift indels contribute to ASD risk (OR = 1.6; 95% CI = 1.0-2.7; p = 0.03), are more common in female probands (p = 0.02), are enriched among genes encoding FMRP targets (p = 6 Ã— 10(-9)), and arise predominantly on the paternal chromosome (p < 0.001). On the basis of mutation rates in probands versus unaffected siblings, we conclude that de novo frameshift indels contribute to risk in approximately 3% of individuals with ASD. Finally, by observing clustering of mutations in unrelated probands, we uncover two ASD-associated genes: KMT2E (MLL5), a chromatin regulator, and RIMS1, a regulator of synaptic vesicle release.},
	Author = {Dong, Shan and Walker, Michael F and Carriero, Nicholas J and DiCola, Michael and Willsey, A Jeremy and Ye, Adam Y and Waqar, Zainulabedin and Gonzalez, Luis E and Overton, John D and Frahm, Stephanie and Keaney, 3rd, John F and Teran, Nicole A and Dea, Jeanselle and Mandell, Jeffrey D and Hus Bal, Vanessa and Sullivan, Catherine A and DiLullo, Nicholas M and Khalil, Rehab O and Gockley, Jake and Yuksel, Zafer and Sertel, Sinem M and Ercan-Sencicek, A Gulhan and Gupta, Abha R and Mane, Shrikant M and Sheldon, Michael and Brooks, Andrew I and Roeder, Kathryn and Devlin, Bernie and State, Matthew W and Wei, Liping and Sanders, Stephan J},
	Date-Added = {2016-07-09 19:58:00 +0000},
	Date-Modified = {2016-07-09 19:58:00 +0000},
	Doi = {10.1016/j.celrep.2014.08.068},
	Journal = {Cell Rep},
	Journal-Full = {Cell reports},
	Mesh = {Child; Child Development Disorders, Pervasive; DNA; DNA-Binding Proteins; Female; Fragile X Mental Retardation Protein; Frameshift Mutation; GTP-Binding Proteins; Humans; Male; Nerve Tissue Proteins; Pedigree; Phenotype; Sequence Deletion; Sex Factors},
	Month = {Oct},
	Number = {1},
	Pages = {16-23},
	Pmc = {PMC4194132},
	Pmid = {25284784},
	Pst = {ppublish},
	Title = {De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder},
	Volume = {9},
	Year = {2014},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.celrep.2014.08.068}}

@article{Dean:2008aa,
	Abstract = {Neurosteroids play an important role in the development of the cerebellum. In particular, estradiol and progesterone appear capable of inducing increases in dendritic spine density during development, and there is evidence that both are synthesized de novo in the cerebellum during critical developmental periods. In normal neonates and adults, there are few differences in the cerebellum between the sexes and most studies indicate that hormone and receptor levels also do not differ significantly during development. However, the sexes do differ significantly in risk of neuropsychological diseases associated with cerebellar pathology, and in animal models there are noticeable sex differences in the response to insult and genetic mutation. In both humans and animals, males tend to fare worse. Boys are more at risk for autism and Attention Deficit Hyperactivity Disorder than girls, and schizophrenia manifests at an earlier age in men. In rats males fare worse than females after perinatal exposure to polychlorinated biphenyls, and male mice heterozygous for the staggerer and reeler mutation show a more severe phenotype. Although very recent evidence suggests that differences in neurosteroid levels between the sexes in diseased animals may play a role in generating different disease phenotypes, the reason this hormonal difference occurs in diseased but not normal animals is currently unknown.},
	Author = {Dean, Shannon L and McCarthy, Margaret M},
	Date-Added = {2016-07-09 19:57:53 +0000},
	Date-Modified = {2016-07-09 19:57:53 +0000},
	Doi = {10.1007/s12311-008-0003-6},
	Journal = {Cerebellum},
	Journal-Full = {Cerebellum (London, England)},
	Mesh = {Animals; Cerebellum; Embryonic Development; Estradiol; Female; Humans; Male; Nervous System Diseases; Progesterone; Rodentia; Sex Characteristics; Spinal Cord},
	Number = {1},
	Pages = {38-47},
	Pmc = {PMC2736099},
	Pmid = {18418672},
	Pst = {ppublish},
	Title = {Steroids, sex and the cerebellar cortex: implications for human disease},
	Volume = {7},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s12311-008-0003-6}}

@article{De-Rubeis:2014aa,
	Abstract = {The genetic architecture of autism spectrum disorder involves the interplay of common and rare variants and their impact on hundreds of genes. Using exome sequencing, here we show that analysis of rare coding variation in 3,871 autism cases and 9,937 ancestry-matched or parental controls implicates 22 autosomal genes at a false discovery rate (FDR) < 0.05, plus a set of 107 autosomal genes strongly enriched for those likely to affect risk (FDR < 0.30). These 107 genes, which show unusual evolutionary constraint against mutations, incur de novo loss-of-function mutations in over 5% of autistic subjects. Many of the genes implicated encode proteins for synaptic formation, transcriptional regulation and chromatin-remodelling pathways. These include voltage-gated ion channels regulating the propagation of action potentials, pacemaking and excitability-transcription coupling, as well as histone-modifying enzymes and chromatin remodellers-most prominently those that mediate post-translational lysine methylation/demethylation modifications of histones.},
	Author = {De Rubeis, Silvia and He, Xin and Goldberg, Arthur P and Poultney, Christopher S and Samocha, Kaitlin and Cicek, A Erucment and Kou, Yan and Liu, Li and Fromer, Menachem and Walker, Susan and Singh, Tarinder and Klei, Lambertus and Kosmicki, Jack and Shih-Chen, Fu and Aleksic, Branko and Biscaldi, Monica and Bolton, Patrick F and Brownfeld, Jessica M and Cai, Jinlu and Campbell, Nicholas G and Carracedo, Angel and Chahrour, Maria H and Chiocchetti, Andreas G and Coon, Hilary and Crawford, Emily L and Curran, Sarah R and Dawson, Geraldine and Duketis, Eftichia and Fernandez, Bridget A and Gallagher, Louise and Geller, Evan and Guter, Stephen J and Hill, R Sean and Ionita-Laza, Juliana and Jimenz Gonzalez, Patricia and Kilpinen, Helena and Klauck, Sabine M and Kolevzon, Alexander and Lee, Irene and Lei, Irene and Lei, Jing and Lehtim{\"a}ki, Terho and Lin, Chiao-Feng and Ma'ayan, Avi and Marshall, Christian R and McInnes, Alison L and Neale, Benjamin and Owen, Michael J and Ozaki, Noriio and Parellada, Mara and Parr, Jeremy R and Purcell, Shaun and Puura, Kaija and Rajagopalan, Deepthi and Rehnstr{\"o}m, Karola and Reichenberg, Abraham and Sabo, Aniko and Sachse, Michael and Sanders, Stephan J and Schafer, Chad and Schulte-R{\"u}ther, Martin and Skuse, David and Stevens, Christine and Szatmari, Peter and Tammimies, Kristiina and Valladares, Otto and Voran, Annette and Li-San, Wang and Weiss, Lauren A and Willsey, A Jeremy and Yu, Timothy W and Yuen, Ryan K C and {DDD Study} and {Homozygosity Mapping Collaborative for Autism} and {UK10K Consortium} and Cook, Edwin H and Freitag, Christine M and Gill, Michael and Hultman, Christina M and Lehner, Thomas and Palotie, Aaarno and Schellenberg, Gerard D and Sklar, Pamela and State, Matthew W and Sutcliffe, James S and Walsh, Christiopher A and Scherer, Stephen W and Zwick, Michael E and Barett, Jeffrey C and Cutler, David J and Roeder, Kathryn and Devlin, Bernie and Daly, Mark J and Buxbaum, Joseph D},
	Date-Added = {2016-07-09 19:57:48 +0000},
	Date-Modified = {2016-07-09 19:57:48 +0000},
	Doi = {10.1038/nature13772},
	Journal = {Nature},
	Journal-Full = {Nature},
	Mesh = {Amino Acid Sequence; Child Development Disorders, Pervasive; Chromatin; Chromatin Assembly and Disassembly; Exome; Female; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Male; Molecular Sequence Data; Mutation; Mutation, Missense; Nerve Net; Odds Ratio; Synapses; Transcription, Genetic},
	Month = {Nov},
	Number = {7526},
	Pages = {209-15},
	Pmc = {PMC4402723},
	Pmid = {25363760},
	Pst = {ppublish},
	Title = {Synaptic, transcriptional and chromatin genes disrupted in autism},
	Volume = {515},
	Year = {2014},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature13772}}

@article{Cotney:2015aa,
	Abstract = {Recent studies implicate chromatin modifiers in autism spectrum disorder (ASD) through the identification of recurrent de novo loss of function mutations in affected individuals. ASD risk genes are co-expressed in human midfetal cortex, suggesting that ASD risk genes converge in specific regulatory networks during neurodevelopment. To elucidate such networks, we identify genes targeted by CHD8, a chromodomain helicase strongly associated with ASD, in human midfetal brain, human neural stem cells (hNSCs) and embryonic mouse cortex. CHD8 targets are strongly enriched for other ASD risk genes in both human and mouse neurodevelopment, and converge in ASD-associated co-expression networks in human midfetal cortex. CHD8 knockdown in hNSCs results in dysregulation of ASD risk genes directly targeted by CHD8. Integration of CHD8-binding data into ASD risk models improves detection of risk genes. These results suggest loss of CHD8 contributes to ASD by perturbing an ancient gene regulatory network during human brain development.},
	Author = {Cotney, Justin and Muhle, Rebecca A and Sanders, Stephan J and Liu, Li and Willsey, A Jeremy and Niu, Wei and Liu, Wenzhong and Klei, Lambertus and Lei, Jing and Yin, Jun and Reilly, Steven K and Tebbenkamp, Andrew T and Bichsel, Candace and Pletikos, Mihovil and Sestan, Nenad and Roeder, Kathryn and State, Matthew W and Devlin, Bernie and Noonan, James P},
	Date-Added = {2016-07-09 19:57:37 +0000},
	Date-Modified = {2016-07-09 19:57:37 +0000},
	Doi = {10.1038/ncomms7404},
	Journal = {Nat Commun},
	Journal-Full = {Nature communications},
	Mesh = {Animals; Autism Spectrum Disorder; Chromatin Assembly and Disassembly; DNA-Binding Proteins; Gene Expression Regulation, Developmental; Gene Knockdown Techniques; Gene Regulatory Networks; Humans; Mice; Models, Neurological; Nervous System; Neural Stem Cells; Transcription Factors},
	Pages = {6404},
	Pmc = {PMC4355952},
	Pmid = {25752243},
	Pst = {epublish},
	Title = {The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment},
	Volume = {6},
	Year = {2015},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/ncomms7404}}

@article{Constantino:2010aa,
	Abstract = {OBJECTIVE: Although the symptoms of autism exhibit quantitative distributions in nature, estimates of recurrence risk in families have never previously considered or incorporated quantitative characterization of the autistic phenotype among siblings.
METHOD: The authors report the results of quantitative characterization of 2,920 children from 1,235 families participating in a national volunteer register, with at least one child clinically affected by an autism spectrum disorder and at least one full biological sibling.
RESULTS: A traditionally defined autism spectrum disorder in an additional child occurred in 10.9% of the families. An additional 20% of nonautism-affected siblings had a history of language delay, one-half of whom exhibited autistic qualities of speech. Quantitative characterization using the Social Responsiveness Scale supported previously reported aggregation of a wide range of subclinical (quantitative) autistic traits among otherwise unaffected children in multiple-incidence families and a relative absence of quantitative autistic traits among siblings in single-incidence families. Girls whose standardized severity ratings fell above a first percentile severity threshold (relative to the general population distribution) were significantly less likely to have elicited community diagnoses than their male counterparts.
CONCLUSIONS: These data suggest that, depending on how it is defined, sibling recurrence in autism spectrum disorder may exceed previously published estimates and varies as a function of family type. The results support differences in mechanisms of genetic transmission between simplex and multiplex autism and advance current understanding of the genetic epidemiology of autism spectrum conditions.},
	Author = {Constantino, John N and Zhang, Yi and Frazier, Thomas and Abbacchi, Anna M and Law, Paul},
	Date-Added = {2016-07-09 19:57:27 +0000},
	Date-Modified = {2016-07-09 19:57:27 +0000},
	Doi = {10.1176/appi.ajp.2010.09101470},
	Journal = {Am J Psychiatry},
	Journal-Full = {The American journal of psychiatry},
	Mesh = {Adolescent; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Language Development Disorders; Male; Molecular Epidemiology; Phenotype; Quantitative Trait, Heritable; Recurrence; Registries; Risk; Sex Factors; Siblings; Speech Disorders; United States},
	Month = {Nov},
	Number = {11},
	Pages = {1349-56},
	Pmc = {PMC2970737},
	Pmid = {20889652},
	Pst = {ppublish},
	Title = {Sibling recurrence and the genetic epidemiology of autism},
	Volume = {167},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1176/appi.ajp.2010.09101470}}

@article{Constantino:2012aa,
	Author = {Constantino, John N and Charman, Tony},
	Date-Added = {2016-07-09 19:56:58 +0000},
	Date-Modified = {2016-07-09 19:56:58 +0000},
	Doi = {10.1016/j.jaac.2012.05.017},
	Journal = {J Am Acad Child Adolesc Psychiatry},
	Journal-Full = {Journal of the American Academy of Child and Adolescent Psychiatry},
	Mesh = {Behavioral Symptoms; Child Development Disorders, Pervasive; Female; Humans; Intellectual Disability; Male; Psychological Techniques},
	Month = {Aug},
	Number = {8},
	Pages = {756-8},
	Pmid = {22840545},
	Pst = {ppublish},
	Title = {Gender bias, female resilience, and the sex ratio in autism},
	Volume = {51},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.jaac.2012.05.017}}

@article{Choleris:2008aa,
	Abstract = {Oestrogens (E) influence the activity of oxytocin (OT) producing neurons and heighten the rate of transcription of the oxytocin receptor (OTR) gene. Working through synergistic activities of two different oestrogen receptors (ERs), likely gene duplication products, in the hypothalamus and amygdala, E supports social recognition by mice. As part of social recognition and approach, it is important for mice to assess the risks of social interactions, thus to reduce the social anxiety. Here we argue that hyperactivity in ascending central nervous system arousal systems would work in the opposite direction: increasing social anxiety by potentiating fear-related mechanisms in the amygdala. In humans, such increased social anxiety might account for some features of autism.},
	Author = {Choleris, Elena and Devidze, Nino and Kavaliers, Martin and Pfaff, Donald W},
	Date-Added = {2016-07-09 19:55:58 +0000},
	Date-Modified = {2016-07-09 19:55:58 +0000},
	Doi = {10.1016/S0079-6123(08)00424-X},
	Journal = {Prog Brain Res},
	Journal-Full = {Progress in brain research},
	Mesh = {Amygdala; Animals; Anxiety; Arousal; Autistic Disorder; Estrogens; Female; Gene Duplication; Gonadal Steroid Hormones; Humans; Hypothalamus; Male; Mice; Neuropeptides; Receptors, Estrogen; Recognition (Psychology); Schizophrenia; Sex Characteristics; Social Behavior; Steroids; Violence},
	Pages = {291-303},
	Pmid = {18655890},
	Pst = {ppublish},
	Title = {Steroidal/neuropeptide interactions in hypothalamus and amygdala related to social anxiety},
	Volume = {170},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/S0079-6123(08)00424-X}}

@article{CARTER:1961aa,
	Author = {CARTER, C O},
	Date-Added = {2016-07-09 19:55:50 +0000},
	Date-Modified = {2016-07-09 19:55:50 +0000},
	Journal = {Br Med Bull},
	Journal-Full = {British medical bulletin},
	Keywords = {PYLORIC STENOSIS/genetics},
	Mesh = {Humans; Pyloric Stenosis},
	Month = {Sep},
	Pages = {251-4},
	Pmid = {13691133},
	Pst = {ppublish},
	Title = {The inheritance of congenital pyloric stenosis},
	Volume = {17},
	Year = {1961}}

@article{Carrel:2005aa,
	Abstract = {In female mammals, most genes on one X chromosome are silenced as a result of X-chromosome inactivation. However, some genes escape X-inactivation and are expressed from both the active and inactive X chromosome. Such genes are potential contributors to sexually dimorphic traits, to phenotypic variability among females heterozygous for X-linked conditions, and to clinical abnormalities in patients with abnormal X chromosomes. Here, we present a comprehensive X-inactivation profile of the human X chromosome, representing an estimated 95% of assayable genes in fibroblast-based test systems. In total, about 15% of X-linked genes escape inactivation to some degree, and the proportion of genes escaping inactivation differs dramatically between different regions of the X chromosome, reflecting the evolutionary history of the sex chromosomes. An additional 10% of X-linked genes show variable patterns of inactivation and are expressed to different extents from some inactive X chromosomes. This suggests a remarkable and previously unsuspected degree of expression heterogeneity among females.},
	Author = {Carrel, Laura and Willard, Huntington F},
	Date-Added = {2016-07-09 19:55:33 +0000},
	Date-Modified = {2016-07-09 19:55:33 +0000},
	Doi = {10.1038/nature03479},
	Journal = {Nature},
	Journal-Full = {Nature},
	Mesh = {Alleles; Chromosomes, Human, X; Chromosomes, Human, Y; CpG Islands; Dosage Compensation, Genetic; Female; Fibroblasts; Gene Expression Profiling; Gene Expression Regulation; Heterozygote; Humans; Male; Phenotype; RNA, Long Noncoding; RNA, Messenger; RNA, Untranslated; Sex Characteristics; Transcription, Genetic},
	Month = {Mar},
	Number = {7031},
	Pages = {400-4},
	Pmid = {15772666},
	Pst = {ppublish},
	Title = {X-inactivation profile reveals extensive variability in X-linked gene expression in females},
	Volume = {434},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nature03479}}

@article{Brown:1982aa,
	Author = {Brown, W T and Friedman, E and Jenkins, E C and Brooks, J and Wisniewski, K and Raguthu, S and French, J H},
	Date-Added = {2016-07-09 19:55:23 +0000},
	Date-Modified = {2016-07-09 19:55:23 +0000},
	Journal = {Lancet},
	Journal-Full = {Lancet (London, England)},
	Mesh = {Adolescent; Autistic Disorder; Child; Chromosome Fragility; Female; Humans; Male; Sex Chromosomes; X Chromosome},
	Month = {Jan},
	Number = {8263},
	Pages = {100},
	Pmid = {6119460},
	Pst = {ppublish},
	Title = {Association of fragile X syndrome with autism},
	Volume = {1},
	Year = {1982}}

@article{Bailey:1995aa,
	Abstract = {Two previous epidemiological studies of autistic twins suggested that autism was predominantly genetically determined, although the findings with regard to a broader phenotype of cognitive, and possibly social, abnormalities were contradictory. Obstetric and perinatal hazards were also invoked as environmentally determined aetiological factors. The first British twin sample has been re-examined and a second total population sample of autistic twins recruited. In the combined sample 60% of monozygotic (MZ) pairs were concordant for autism versus no dizygotic (DZ) pairs; 92% of MZ pairs were concordant for a broader spectrum of related cognitive or social abnormalities versus 10% of DZ pairs. The findings indicate that autism is under a high degree of genetic control and suggest the involvement of multiple genetic loci. Obstetric hazards usually appear to be consequences of genetically influenced abnormal development, rather than independent aetiological factors. Few new cases had possible medical aetiologies, refuting claims that recognized disorders are common aetiological influences.},
	Author = {Bailey, A and Le Couteur, A and Gottesman, I and Bolton, P and Simonoff, E and Yuzda, E and Rutter, M},
	Date-Added = {2016-07-09 19:53:38 +0000},
	Date-Modified = {2016-07-09 19:53:38 +0000},
	Journal = {Psychol Med},
	Journal-Full = {Psychological medicine},
	Mesh = {Abnormalities, Multiple; Adolescent; Adult; Autistic Disorder; Child; Child, Preschool; Diseases in Twins; Female; Follow-Up Studies; Great Britain; Humans; Infant; Infant, Newborn; Intelligence; Male; Models, Genetic; Personality Assessment; Pregnancy; Prenatal Exposure Delayed Effects; Risk Factors; Social Adjustment; Social Environment; Twins, Dizygotic; Twins, Monozygotic},
	Month = {Jan},
	Number = {1},
	Pages = {63-77},
	Pmid = {7792363},
	Pst = {ppublish},
	Title = {Autism as a strongly genetic disorder: evidence from a British twin study},
	Volume = {25},
	Year = {1995}}
